The DOI matches its Crossref record; 526 of the 538 references it cites were found in a registry or an index; 137 of the 627 sources its claims cite were checked for support.
Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Open accessAbstract
Background and Purpose—: This scientific statement provides an overview of the evidence on vascular contributions to cognitive impairment and dementia. Vascular contributions to cognitive impairment and dementia of later life are common. Definitions of vascular cognitive impairment (VCI), neuropathology, basic science and pathophysiological aspects, role of neuroimaging and vascular and other associated risk factors, and potential opportunities for prevention and treatment are reviewed. This statement serves as an overall guide for practitioners to gain a better understanding of VCI and dementia, prevention, and treatment. Methods—: Writing group members were nominated by the writing group co-chairs on the basis of their previous work in relevant topic areas and were approved by the American Heart Association Stroke Council Scientific Statement Oversight Committee, the Council on Epidemiology and Prevention, and the Manuscript Oversight Committee. The writing group used systematic literature reviews (primarily covering publications from 1990 to May 1, 2010), previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and, when appropriate, formulate recommendations using standard American Heart Association criteria. All members of the writing group had the opportunity to comment on the recommendations and approved the final version of this document. After peer review by the American Heart Association, as well as review by the Stroke Council leadership, Council on Epidemiology and Prevention Council, and Scientific Statements Oversight Committee, the statement was approved by the American Heart Association Science Advisory and Coordinating Committee. Results—: The construct of VCI has been introduced to capture the entire spectrum of cognitive disorders associated with all forms of cerebral vascular brain injury—not solely stroke—ranging from mild cognitive impairment through fully developed dementia. Dysfunction of the neurovascular unit and mechanisms regulating cerebral blood flow are likely to be important components of the pathophysiological processes underlying VCI. Cerebral amyloid angiopathy is emerging as an important marker of risk for Alzheimer disease, microinfarction, microhemorrhage and macrohemorrhage of the brain, and VCI. The neuropathology of cognitive impairment in later life is often a mixture of Alzheimer disease and microvascular brain damage, which may overlap and synergize to heighten the risk of cognitive impairment. In this regard, magnetic resonance imaging and other neuroimaging techniques play an important role in the definition and detection of VCI and provide evidence that subcortical forms of VCI with white matter hyperintensities and small deep infarcts are common. In many cases, risk markers for VCI are the same as traditional risk factors for stroke. These risks may include but are not limited to atrial fibrillation, hypertension, diabetes mellitus, and hypercholesterolemia. Furthermore, these same vascular risk factors may be risk markers for Alzheimer disease. Carotid intimal-medial thickness and arterial stiffness are emerging as markers of arterial aging and may serve as risk markers for VCI. Currently, no specific treatments for VCI have been approved by the US Food and Drug Administration. However, detection and control of the traditional risk factors for stroke and cardiovascular disease may be effective in the prevention of VCI, even in older people. Conclusions—: Vascular contributions to cognitive impairment and dementia are important. Understanding of VCI has evolved substantially in recent years, based on preclinical, neuropathologic, neuroimaging, physiological, and epidemiological studies. Transdisciplinary, translational, and transactional approaches are recommended to further our understanding of this entity and to better characterize its neuropsychological profile. There is a need for prospective, quantitative, clinical-pathological-neuroimaging studies to improve knowledge of the pathological basis of neuroimaging change and the complex interplay between vascular and Alzheimer disease pathologies in the evolution of clinical VCI and Alzheimer disease. Long-term vascular risk marker interventional studies beginning as early as midlife may be required to prevent or postpone the onset of VCI and Alzheimer disease. Studies of intensive reduction of vascular risk factors in high-risk groups are another important avenue of research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
137 of 627 cited sources checked · 45 supported · 6 flagged · accuracy not yet measured
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“High waist-hip ratio strengthened the association with hypertension and dementia in the highest quartile of waist-hip ratio.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
- Disputedcites [322] sourceExperimental — accuracy not yet measured
The Results (page unavailable) report no significant association between late-life waist–hip ratio and dementia. The Discussion (page unavailable) likewise states that the authors found no association for waist–hip ratio in old age; it does not report a strengthened hypertension–dementia association in the highest waist–hip-ratio quartile. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A study of 6 months’ duration in elderly women provides support, using rigorous controlled methodology, for a potent nonpharmacological intervention that improves executive control processes for older women at high risk of cognitive decline.473”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.6. Other Interventions for Vascular Factors
What the sources say
- Disputedcites [473] sourceExperimental — accuracy not yet measured
The Discussion reports a five-year trial of daily low-dose aspirin, a pharmacological intervention, in men and women over 50—not a six-month nonpharmacological study in elderly women. It found no significant cognitive benefit, including on measures of executive function. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, WMLs also occur in older subjects and patients with Alzheimer disease in epidemiological studies.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.2. Clinical Criteria for the Diagnosis of VaD
What the sources say
- Supportedcites [34] source
The Methods describe MRI assessment of white matter grade in the Cardiovascular Health Cognition Study, an older cohort. Results Table 3 reports high white matter grade in groups later classified with Alzheimer disease, including those without vascular dementia. Page numbers are unavailable in our copy. (LLM, conf=0.91)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Several studies have shown that patients with MCI can return to normal cognition.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.5. Reversibility of VaMCI
What the sources say
- Not checked — no full text of the sourcecites [44] source
- Could not verifycites [45] sourceExperimental — accuracy not yet measured
The Materials and Methods (p. 2) say this paper reports cognitive performance at a baseline visit, not whether patients later returned to normal cognition. The Discussion (p. 5) says cognitive dysfunction may persist after depression is treated, but does not address recovery from mild cognitive impairment. Searches for return to normal cognition and cognitive recovery found no supporting passage. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [46] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“occur commonly in older people with and without dementia”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects
What the sources say
- Not checked — no full text of the sourcecites [13] source
- Not checked — no full text of the sourcecites [39] source
- Not checked — no full text of the sourcecites [53] source
- Supportedcites [54] sourceExperimental — accuracy not yet measured
The Results sections on people with no cognitive impairment and on people with dementia both report cerebral infarcts. The paper does not give an infarct percentage in those passages, but its findings support the broad claim that infarcts occur in older people with and without dementia. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [55] source
- Not checked — no full text of the sourcecites [56] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“typically are accompanied by Alzheimer disease and other pathologies.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects
What the sources say
- Not checked — no full text of the sourcecites [12] source
- Not checked — no full text of the sourcecites [13] source
- Not checked — no full text of the sourcecites [16] source
- Not checked — no full text of the sourcecites [17] source
- Partly supportedcites [54] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says dementia, including probable AD, is often associated with mixed pathology involving AD, cerebral infarcts, and/or Lewy bodies. The Results and Discussion (pages unavailable) also report infarcts alongside mixed pathologies in community participants with probable AD. These passages support co-occurrence, but they do not establish the broader claim that infarcts are typically accompanied by AD and other pathologies. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [55] source
- Not checked — no full text of the sourcecites [56] source
- Not checked — no full text of the sourcecites [57] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“neuroimaging studies have shown that white matter degeneration, as measured by both fluid-attenuated inversion recovery and diffusion tensor imaging, and microbleeds are associated with both VCI and clinical Alzheimer disease,70,72,76,77,81”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.6. Neuroimaging and Pathology: Future Directions
What the sources say
- Not checked — no full text of the sourcecites [70] source
- Not checked — no full text of the sourcecites [72] source
- Partly supportedcites [76] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) calls brain microbleeds a biomarker of cerebrovascular disease, and the Discussion reports that participants with microbleeds were more likely to progress to dementia. The paper does not establish the claimed association of white matter degeneration with both vascular cognitive impairment and clinical Alzheimer disease. Its MR imaging Methods list FLAIR but not diffusion tensor imaging, and its cognitive-testing Methods say participants developing a disorder other than Alzheimer disease were removed. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [77] source
- Not checked — no full text of the sourcecites [81] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.3. Relation of Infarcts to Alzheimer Disease Pathology and Dementia
What the sources say
- Not checked — no full text of the sourcecites [12] source
- Not checked — no full text of the sourcecites [13] source
- Not checked — no full text of the sourcecites [16] source
- Not checked — no full text of the sourcecites [17] source
- Supportedcites [54] source
The Introduction says that dementia, including probable Alzheimer’s disease, in community-based older persons is often associated with mixed pathology—specifically AD pathology together with cerebral infarcts and/or Lewy bodies. The Discussion also reports that infarcts and mixed pathologies were more common among community participants with probable AD than among clinic participants. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [55] source
- Not checked — no full text of the sourcecites [56] source
- Not checked — no full text of the sourcecites [57] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesEvery source the paper cites for this claim was checked and supports it.
In the paper
“In 1 study the frequency of pure infarct and mixed Alzheimer disease and infarct pathology was comparable to the frequency of pure Alzheimer disease pathology in both amnestic and nonamnestic MCI.61”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.4. Relation of Infarcts to Alzheimer Disease Pathology and MCI
What the sources say
- Supportedcites [61] source
The Results (Mild Cognitive Impairment; page unavailable) report pure AD pathology in 36% of amnestic and 33.9% of nonamnestic MCI cases. Pure infarcts plus mixed pathologies total 36.0% and 33.9%, respectively; the same section identifies AD with infarcts as the most common mixed pathology. These figures support the cited comparison. (LLM, conf=0.86)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“but mixed pathologies are also common.61,65–69”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.4. Relation of Infarcts to Alzheimer Disease Pathology and MCI
What the sources say
- Supportedcites [61] source
The Discussion describes mixed pathologies as “not an infrequent finding in MCI,” particularly amnestic MCI. The Results report mixed pathologies in 19.4% of people with MCI, supporting the claim that they are also common in this group. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [65] source
- Not checked — no full text of the sourcecites [66] source
- Not checked — no full text of the sourcecites [67] source
- Not checked — no full text of the sourcecites [68] source
- Not checked — no full text of the sourcecites [69] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
- It may state two separate claims as one. 168
- Probably not a substantial claim. 47
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Vascular oxidative stress and inflammation impede the proliferation, migration, and differentiation of oligodendrocyte progenitor cells and compromise repair of the damaged white matter.108,132,133”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation
What the sources say
- Not checked — no full text of the sourcecites [108] source
- Partly supportedcites [132] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that cultured rat OPCs were vulnerable to hydrogen-peroxide oxidative stress, and the paper states that OPCs contribute to white-matter repair. It does not show that vascular oxidative stress or inflammation impedes OPC proliferation, migration, or differentiation, or directly demonstrate impaired repair of damaged white matter. (LLM, conf=0.88)
- Disputedcites [133] sourceExperimental — accuracy not yet measured
The Discussion states that the inflammatory response associated with demyelination provides a powerful impetus for remyelination—the opposite of the claim that inflammation impedes repair. The paper attributes impaired progenitor recruitment and differentiation to aging, but the cited passages do not establish vascular oxidative stress as their cause. No page number is supplied in our copy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“It is unclear what confounding factors were taken into account in these analyses.322”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
- Disputedcites [322] sourceExperimental — accuracy not yet measured
The Methods section explicitly states which factors were included in the adjusted models, including demographics, cardiovascular and dementia risk factors, smoking, physical activity, and ApoE genotype. The claim that it is unclear which confounding factors were taken into account is therefore contrary to the cited paper's account. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“The risk of new-onset dementia after a stroke is approximately twice the rate for age- and sex-matched control subjects270 and averages ≈10% after the first stroke, depending on the location, volume of damaged brain tissue,30 clinical severity, and presence of early poststroke complications (seizure, delirium, hypoxia, hypotension).”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.2. Stroke
What the sources say
- Not checked — no full text of the sourcecites [270] source
- Disputedcites [30] sourceExperimental — accuracy not yet measured
The citation is attached to the claim that new-onset dementia risk is approximately twice that of age- and sex-matched controls. The Results report an adjusted odds ratio of 9.4 for dementia after stroke versus stroke-free controls, and the methods say the groups differed by sex; the study assessed dementia three months after stroke rather than establishing new onset. The later ≈10% and complication claims are not attached to this citation. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“(3) patients at low risk for dementia (young mean age)441,445 and with high baseline MMSE;”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
What the sources say
- Disputedcites [441] sourceExperimental — accuracy not yet measured
The Methods (Selection) explicitly exclude pharmaceutical clinical trial volunteers and restrict the review to community-dwelling adults aged 60 or older. The Results (Cognitive Dysfunction) describe population-based prospective studies with mean baseline ages including 68.9, 75.6, and 83 years, rather than trials characterized by a young mean age. The paper mentions MMSE as an outcome measure but does not establish that participants had high baseline MMSE scores. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [445] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Executive dysfunction has not been shown to specifically point to cerebrovascular disease, whereas a pattern of memory deficits may be associated more with Alzheimer disease and its associated pathology than with cerebrovascular disease.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.6. Neuropsychological Assessments of VCI
What the sources say
- Not checked — no full text of the sourcecites [49] source
- Supportedcites [50] source
The Discussion (page not specified) says severe memory impairment strongly points to Alzheimer-type brain pathology, while executive deficits are a much weaker diagnostic marker of vascular disease. It relates this finding in MCI patients to reported results in patients with autopsy-defined Alzheimer and vascular pathology. (LLM, conf=0.91)
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic macroscopic infarcts are very common, occurring in approximately one third to one half of older people,13,54–56 a frequency far greater than the frequency of clinical stroke.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.1. Cerebral Infarctions Are Very Common in Older People
What the sources say
- Not checked — no full text of the sourcecites [13] source
- Partly supportedcites [54] sourceExperimental — accuracy not yet measured
The Results (Probable AD in the community versus clinic; page unavailable) report that macroscopic infarcts were more common in the community cohort than in the clinic cohort. The available passages do not establish that they occurred in one third to one half of older people or that their frequency was far greater than that of clinical stroke. (LLM, conf=0.81)
- Not checked — no full text of the sourcecites [55] source
- Not checked — no full text of the sourcecites [56] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There are other common vascular pathologies in the brains of older people, including white matter degeneration70,71 and primary vessel disease (ie, arteriolosclerosis/lipohyalinosis, atherosclerosis, and cerebral amyloid angiopathy [CAA]).70,72,73”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.5. Other Vascular Pathologies
What the sources say
- Not checked — no full text of the sourcecites [70] source
- Not checked — no full text of the sourcecites [71] source
- Not checked — no full text of the sourcecites [72] source
- Partly supportedcites [73] sourceExperimental — accuracy not yet measured
The Discussion (page not available) says sclerotic medullary arteries are commonly seen in older people and that some are associated with diffuse ischemic white matter change. The Results (page not available) describe fibrohyaline thickening but state that atherosclerosis and amyloid angiopathy were not observed in the medullary arteries. This paper therefore supports part of the broad claim, not the full list of vessel diseases as common findings in its studied arteries. (LLM, conf=0.88)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although the specific importance of subcortical infarcts and interaction has not been confirmed, subsequent studies have established that infarcts are additive with Alzheimer disease pathology in lowering cognitive function17,57 and increasing the odds of dementia17,18,62,63 or clinical Alzheimer disease.61”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.3. Relation of Infarcts to Alzheimer Disease Pathology and Dementia
What the sources say
- Not checked — no full text of the sourcecites [17] source
- Not checked — no full text of the sourcecites [57] source
- Not checked — no full text of the sourcecites [18] source
- Partly supportedcites [62] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [63] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [61] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition, most people with dementia12 and almost half of those with clinically probable Alzheimer disease61 have mixed pathology, most commonly Alzheimer disease and infarcts.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.3. Relation of Infarcts to Alzheimer Disease Pathology and Dementia
What the sources say
- Not checked — no full text of the sourcecites [12] source
- Supportedcites [61] source
The Results section on probable Alzheimer disease reports mixed pathologies in 45.8% of people with clinically probable AD and identifies AD with infarcts as the most common combination. The separate claim about most people with dementia is attached to citation 12, not this source. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In animal models, the major risk factors for VCI and Alzheimer disease —hypertension, aging, and diabetes110—impair endothelium-dependent responses in the cerebral microcirculation and blunt functional hyper-emia.101,111,112”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.2. The Neurovascular Unit: A Target of Vascular and Neurodegenerative Dementias
What the sources say
- Not checked — no full text of the sourcecites [110] source
- Not checked — no full text of the sourcecites [101] source
- Partly supportedcites [111] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that aging impairs endothelial function in mouse cerebral arteries and states that neurovascular coupling decreases with aging. The study tested isolated basilar arteries, not functional hyperemia, and the cited passages do not establish the claimed effects of hypertension or diabetes. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [112] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.1. The Neurovascular Unit and Brain Homeostasis
What the sources say
- Not checked — no full text of the sourcecites [91] source
- Supportedcites [92] source
Citation 92 is attached to immune surveillance in concert with perivascular cells, not to local flow distribution or hemostatic balance. The Discussion (‘What are perivascular cells?’; page unavailable) explicitly says perivascular cells participate in nervous-system immune surveillance, while the Introduction describes their interaction with endothelial cells in responses to immune signals. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [93] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Cerebral smooth muscle cells of patients with Alzheimer disease have increased constrictor tone,118 which may contribute to the CBF reduction observed in this condition.100”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.2. The Neurovascular Unit: A Target of Vascular and Neurodegenerative Dementias
What the sources say
- Supportedcites [118] source
The Discussion reports that vascular smooth muscle cells from the cerebral vessels of patients with Alzheimer disease had a hypercontractile phenotype. It also suggests this phenotype could contribute to brain hypoperfusion, although the citing sentence attaches this source specifically to the increased-constrictor-tone clause. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [100] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Microvessels have thickened basement membranes, become tortuous, and are reduced in number.71,105–107”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.2. The Neurovascular Unit: A Target of Vascular and Neurodegenerative Dementias
What the sources say
- Not checked — no full text of the sourcecites [71] source
- Not checked — no full text of the sourcecites [105] source
- Partly supportedcites [106] sourceExperimental — accuracy not yet measured
The Introduction describes tortuosity in arterioles supplying the deep white matter in leukoaraiosis, while the Abstract reports reduced microvascular density in leukoaraiosis and preliminary evidence of reduced density in Alzheimer’s disease. Neither passage describes thickened basement membranes, and the tortuosity finding is not established for Alzheimer’s disease. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [107] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The brain depends on a continuous blood supply, and interruption of cerebral blood flow (CBF) leads to brain dysfunction and death.86”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.1. The Neurovascular Unit and Brain Homeostasis
What the sources say
- Supportedcites [86] source
The “Parenchymal Failure” section says the brain is especially vulnerable to ischemia: neurological dysfunction occurs within seconds to minutes of vessel occlusion, while injury and cell death develop over time. Its discussion of salvageable tissue also explains that tissue with impaired perfusion dies unless perfusion improves or cells are protected. (LLM, conf=0.93)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Endothelial cells exert trophic actions that are critical in brain development, neuroplasticity, and repair when endothelial growth factors orchestrate the migration and differentiation of neuroblasts.96–99”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.1. The Neurovascular Unit and Brain Homeostasis
What the sources say
- Not checked — no full text of the sourcecites [96] source
- Partly supportedcites [97] sourceExperimental — accuracy not yet measured
The Discussion reports that endothelial cells secrete factors regulating neuronal differentiation in vitro and that vascular ligands guide neuroblast migration after stroke. It does not establish that those ligands orchestrate neuroblast differentiation, or that these actions are critical across brain development and neuroplasticity. The relevant indexed passages have no page numbers. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [98] source
- Not checked — no full text of the sourcecites [99] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the low-density lipoprotein receptor–related protein-1, a critical Aβ brain clearance receptor, is downregulated in cerebral blood vessels of patients with Alzheimer disease, leading to accumulation of amyloid around blood vessels and worsening of vascular dysfunction.129”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation
What the sources say
- Partly supportedcites [129] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Pittsburgh Compound B retention is not specific for CAA as opposed to Alzheimer disease, because the compound binds to both vascular and parenchymal amyloid158; however, the 2 pathologies may be distinguishable in part by the relative occipital predominance of labeling in CAA.156,157”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.1. Cerebral Amyloid Angiopathy and Vascular Effects of Aβ
What the sources say
- Partly supportedcites [158] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [156] source
- Not checked — no full text of the sourcecites [157] source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“a single nucleotide polymorphism in the COL4A1 gene was associated with pulse wave velocity, an index of arterial stiffness, in a population.180”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.2. Hereditary Small-Vessel Syndromes
What the sources say
- Supportedcites [180] source
The Abstract Background identifies pulse wave velocity (PWV) as an index of central arterial stiffness. The Abstract Methods and Results reports that the COL4A1 SNP rs3742207 was associated with PWV in the Sardinian cohort and that the association was replicated in an Old Order Amish population. (LLM, conf=0.95)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of multiple strictly lobar hemorrhages in the absence of other definite causes such as head trauma, brain tumor, or supratherapeutic anticoagulation has been defined by the Boston criteria as “probable CAA” and validated against neuropathologically or genetically diagnosed CAA.153,154”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.1. Cerebral Amyloid Angiopathy and Vascular Effects of Aβ
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The lumen-intima and media-adventitia separation can be determined to within ≈0.1 mm on longitudinal B-mode ultrasound images of the extracranial carotid arteries where these interfaces are readily apparent.183,184”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.1. Carotid Intima-Media Thickness and VCI
What the sources say
- Not checked — no full text of the sourcecites [183] source
- Partly supportedcites [184] sourceExperimental — accuracy not yet measured
The Subjects and Methods section (page not specified in our copy) describes measurements of the far-wall intimal-medial thickness in extracranial carotid arteries and reports approximately 0.10 mm axial resolution. That is the minimum spacing at which adjacent boundaries can be distinguished, not a demonstrated measurement accuracy of within 0.1 mm; the paper also does not specify longitudinal images for this claim. (LLM, conf=0.82)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Mutations of the COL4A1 type IV collagen subunit gene have also been reported in association with congenital porencephaly, leukoencephalopathy, or intracerebral hemorrhage.178,179”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.2. Hereditary Small-Vessel Syndromes
What the sources say
- Supportedcites [178] source
The paper’s Results and Conclusions report COL4A1 mutations in families with porencephaly and identify a predisposition to perinatal cerebral haemorrhage. The Affected section also describes white-matter lesions in mutation carriers, supporting the leukoencephalopathy part of the paraphrase. Passage-level page numbers are not available in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [179] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Other potential diagnostic approaches have been explored, including detection of reduced Aβ in cerebrospinal fluid155 or increased retention of the amyloid ligand Pittsburgh Compound B on positron emission tomography imaging.156,157”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.1. Cerebral Amyloid Angiopathy and Vascular Effects of Aβ
What the sources say
- Supportedcites [155] source
The Discussion reports decreased CSF Aβ40 and Aβ42 in patients with cerebral amyloid angiopathy and says CSF analysis may help identify them. This supports the potential CSF diagnostic approach attributed to this source; the PET approach has separate citations. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [156] source
- Not checked — no full text of the sourcecites [157] source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although no treatments have been identified to modify the course of CADASIL, it is notable that cardiovascular risk factors such as hypertension, elevated hemoglobin A1c, and smoking may be associated with a worse clinical and radiographic phenotype.171,172”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.2. Hereditary Small-Vessel Syndromes
What the sources say
- Not checked — no full text of the sourcecites [171] source
- Partly supportedcites [172] sourceExperimental — accuracy not yet measured
The Results (Presence of CM and associated factors; Cerebral microhaemorrhages and neurological outcome, pages unavailable) associate hypertension and elevated HbA1c with microhaemorrhages, and systolic blood pressure with poor functional outcome. The Discussion says treatment benefits remain to be tested. But the study does not support including smoking: its tables show no significant association with either microhaemorrhages or poor functional outcome. (LLM, conf=0.90)
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Several pathways may link aortic stiffness to microvascular brain damage. They include endothelial dysfunction and oxidative stress,209 a mutually reinforcing remodeling of large and small vessels (ie, large-/small-artery cross talk),210 and exposure of small vessels to the high-pressure fluctuations of the cerebral circulation,211”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.2. Arterial Stiffness and VCI
What the sources say
- Not checked — no full text of the sourcecites [209] source
- Not checked — no full text of the sourcecites [210] source
- Supportedcites [211] source
Citation 211 is attached to the claim that small cerebral vessels are exposed to high-pressure fluctuations, not to the preceding pathways. The Abstract (p. 200) says that high flow and low resistance expose small vessels to pressure fluctuations in the carotid and vertebral arteries, providing a proposed explanation for microvascular damage. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Retinal arterial narrowing correlates with increased arterial stiffness219 and cerebral small-vessel disease.218,220,221”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.3. Small-Artery Remodeling and VCI
What the sources say
- Supportedcites [219] source
Citation 219 supports the arterial-stiffness portion of the sentence; the cerebral small-vessel disease portion has separate citations. The Discussion (page not supplied) reports an association between aortic stiffening and retinal arteriolar narrowing in participants free of clinical cardiovascular disease. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [218] source
- Not checked — no full text of the sourcecites [220] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The well-known, age-related arterial stiffening process (arteriosclerosis) is associated with quantitatively less elastin and more collagen but is also associated with qualitative changes in the arterial wall.143,199,200”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.2. Arterial Stiffness and VCI
What the sources say
- Not checked — no full text of the sourcecites [143] source
- Partly supportedcites [199] sourceExperimental — accuracy not yet measured
In “Determinants of Arterial Stiffness” (page not available), the paper links aging to thinning and fragmentation of elastic fibers, increased collagenous material, and qualitative changes in the arterial wall. It does not explicitly establish a quantitative decrease in elastin, so that part of the claim is not fully supported. (LLM, conf=0.83)
- Partly supportedcites [200] sourceExperimental — accuracy not yet measured
The Essential Hypertension section (page unavailable) says central arteries stiffen with age, elastic fibers lose their orderly arrangement and undergo thinning and fragmentation, and collagenous material increases. These passages support age-related stiffening, increased collagen, and qualitative wall changes, but they do not establish a quantitative decrease in elastin content. (LLM, conf=0.84)
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This relationship was significant after controlling for age and education; some studies further adjusted for the presence of depressive symptoms187,189 and/or cardiovascular risk factor level.189”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.1. Carotid Intima-Media Thickness and VCI
What the sources say
- Not checked — no full text of the sourcecites [187] source
- Supportedcites [189] source
The Abstract’s Methods section says the analyses adjusted for age, education, depressive symptoms, and cardiovascular risk factors including mean arterial pressure, body mass index, total cholesterol, and smoking. The Abstract’s Results section reports accelerated cognitive decline among participants with greater carotid IMT after those adjustments. The supplied passages do not give page numbers. (LLM, conf=0.93)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The mechanisms by which atherosclerotic cerebrovascular pathology might be associated with VCI include thrombotic occlusion of large vessels with subsequent chronic cerebral hypoperfusion; cerebral embolism originating from ruptured or thrombotic carotid plaques and targeting distal vessels; increased parenchymal oxidative stress; blood pressure dys-regulation affecting BBB integrity; and a common”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.1. Carotid Intima-Media Thickness and VCI
What the sources say
- Partly supportedcites [189] sourceExperimental — accuracy not yet measured
The Discussion proposes chronic cerebral hypoperfusion as a mechanism linking subclinical vascular disease to cognitive impairment. It does not specify thrombotic large-vessel occlusion as its cause, or describe plaque-derived embolism, parenchymal oxidative stress, or blood-pressure dysregulation affecting blood–brain barrier integrity. No page number is available in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [195] source
- Partly supportedcites [196] sourceExperimental — accuracy not yet measured
The Discussion (page not provided) proposes chronic cerebral hypoperfusion as a contributor to brain dysfunction in patients with cardiovascular disease. The Abstract (page not provided) also links atherosclerosis to cerebral vessel changes and blood-pressure abnormalities to impaired cerebral hemodynamics. Our copy does not support the specified mechanisms of large-vessel thrombotic occlusion, carotid-plaque embolism, oxidative stress, or blood-pressure effects on blood–brain barrier integrity. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [197] source
- Partly supportedcites [198] sourceExperimental — accuracy not yet measured
The “Carotid Disease and the Brain” section (page unavailable) proposes large-vessel occlusion with hypoperfusion and embolism from ruptured or thrombotic carotid plaques. It does not describe the hypoperfusion as chronic or propose oxidative stress or blood-pressure dysregulation affecting blood–brain barrier integrity as mechanisms. (LLM, conf=0.90)
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Importantly, age-specific definitions of extensive WMLs can be created240 and prove useful in defining risk for VCI in a community cohort.240”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Partly supportedcites [240] sourceExperimental — accuracy not yet measured
The Methods (MRI scans; page not provided) define extensive white matter hyperintensity volume using age-specific thresholds. The Results and Discussion report that this measure predicted incident dementia in a community cohort and amnestic MCI only among participants aged 60 or older. The study did not specifically establish risk for vascular cognitive impairment (VCI). (LLM, conf=0.86)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Similarly, WMLs have been associated with declining scores in the modified MMSE and the Digit Symbol Substitution Test,246,247 as well as with incident MCI, dementia, and death.240”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Partly supportedcites [240] sourceExperimental — accuracy not yet measured
The Results sections on dementia, MCI, and mortality associate white matter hyperintensity measures with incident dementia and death. For MCI, however, the paper finds no overall association; increased risk of amnestic MCI appears only in certain subgroups, including participants aged 60 or older. The unqualified reference to incident MCI overstates that finding. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Estimates of the prevalence of silent cerebral infarction on MRI in community-based samples vary between 5.8% and 17.7%, with an average of 11%, depending on age, ethnicity, presence of comorbidities, and imaging techniques.237”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Partly supportedcites [237] sourceExperimental — accuracy not yet measured
The Abstract’s Background and Purpose gives the 5.8%–17.7% range for community-based MRI samples and attributes variation to age, ethnicity, comorbidities, and imaging techniques. It does not give an 11% average across those samples; the Abstract’s Results report 10.7% for the Framingham sample alone. (LLM, conf=0.86)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Interestingly, although most studies suggest that these measures of CVBI are usually associated with non–memory-related cognitive deficits,241 a number of studies also show similar associations with memory impairment.240,242,243”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Not checked — no full text of the sourcecites [241] source
- Supportedcites [240] source
The citation is attached to the sentence’s memory-impairment claim, not its statement about non-memory deficits. In Results (page not provided), the paper reports that white matter hyperintensity measures were associated with incident amnestic mild cognitive impairment among participants aged 60 or older, providing an example of the claimed association. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [242] source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Most have a single lesion, and the infarcts are most often located in the basal ganglia (52%), followed by other subcortical (35%) and cortical (11%) areas.237”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Supportedcites [237] source
The Abstract’s Results report that 84% of participants with silent cerebral infarcts had a single lesion. They give the same location breakdown: 52% basal ganglia, 35% other subcortical areas, and 11% cortical areas. (LLM, conf=0.95)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the Framingham study, for example, the prevalence of silent cerebral infarction between the fifth and seventh decades of life is ≈10% but increases rapidly in the eighth decade to 17% and in the ninth decade to nearly 30%.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Partly supportedcites [237] sourceExperimental — accuracy not yet measured
The Results report 10.7% prevalence overall in the Framingham Offspring sample and an increase with age, from under 8% at ages 30–49 to over 15% at ages 70–89. Our copy does not give the claimed decade-specific figures of 17% in the eighth decade or nearly 30% in the ninth; the Results refer to Figure 1 for age-specific data without stating those values in the retrieved text. (LLM, conf=0.83)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Gray matter volumes, however, were associated with both vascular and Alzheimer disease processes, and hippocampal volumes were associated with both hippocampal sclerosis and Alzheimer disease.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.1. Clinical Presentation and Importance of Neuroimaging Studies
What the sources say
- Supportedcites [82] source
The Results section (‘Associations between Magnetic Resonance Hippocampal Volume and Pathology’) reports that Alzheimer disease pathology and hippocampal sclerosis were both inverse correlates of hippocampal volume and jointly accounted for 33% of its variance. The Discussion also states that hippocampal volume is related to both processes. (LLM, conf=0.95)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, the presence of SBI more than doubles the risk of dementia and risk of stroke.240,244,245”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Partly supportedcites [240] sourceExperimental — accuracy not yet measured
The indexed Results summary reports that MRI-defined brain infarcts (BI) were associated with more than double the risk of incident stroke (HR 2.84) and dementia (HR 6.12). However, the Methods define BI by MRI appearance, not by whether the infarct was silent; the Results also include participants with prior stroke. The reported estimates therefore do not specifically establish the claim for silent brain infarcts (SBI). (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [244] source
- Not checked — no full text of the sourcecites [245] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a study that examined the pathological correlates of in vivo MRI evidence of CVBI,82 WMLs were highly correlated with pathological features of ischemic white matter injury but not Alzheimer disease pathology.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.1. Clinical Presentation and Importance of Neuroimaging Studies
What the sources say
- Supportedcites [82] source
The Discussion reports that white matter hyperintensities (WMH) were associated with vascular disease and complete or incomplete infarction, but not with AD pathology. The Results add that white matter pathology and age explained 32% of WMH variance in the final multivariate model. An unadjusted analysis did find a correlation with AD pathology, so the ‘not with AD’ finding refers to the paper’s adjusted interpretation. (LLM, conf=0.90)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The cognitive tests for VCI are, to a degree, nonspecific for vascular disease, and different criteria for VaD identify different sets of people.29”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline
What the sources say
- Supportedcites [29] source
The Discussion (page not available in our copy) reports that executive-function scores did not differ between VaD and non-VaD subgroups and that AD can contribute to the executive deficits seen in VaD, supporting the qualified point that cognitive tests are not specific to vascular disease. It also says different VaD criteria missed different MRI-confirmed cases; the Criteria agreement section reports disagreement among the criteria. (LLM, conf=0.88)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies have shown that similar to Western countries, Alzheimer disease is the leading cause of dementia in Asian populations.275”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
- Partly supportedcites [275] sourceExperimental — accuracy not yet measured
The Results (p. 3) report that Alzheimer’s disease accounted for most dementia cases in this US cohort, supporting the Western comparison. The paper does not report whether it is the leading cause of dementia in Asian populations, which is the claim’s central point. (LLM, conf=0.82)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“In a pooled analysis of major European population–based studies, VaD was prevalent in 1.6% of subjects >65 years of age, but there was a large variation in 5-year age-specific prevalence.264”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
- Could not verifycites [264] sourceExperimental — accuracy not yet measured
The Results and Statistical analysis sections describe a Boston dietary-questionnaire validation sample, not a pooled analysis of European population-based studies. Searches for vascular dementia, 1.6% prevalence, and five-year age-specific prevalence found no passage addressing the claim. (LLM, conf=0.76)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Recently, 1 study found an association of lower circulating vitamin D levels with poorer cognitive function,294 but another found no association.295”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
- Not checked — no full text of the sourcecites [294] source
- Supportedcites [295] source
The Discussion reports that low circulating 25(OH)D was associated with impaired cognitive function in elders receiving home health services. The Results also report significant associations with several tests of executive function and attention. The separate finding of no association is attributed to citation 295, not this paper. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This age-related increase in VaD follows the pattern of stroke,269 although dementia after stroke may be more frequent in people <80 years old.270”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
- Partly supportedcites [269] sourceExperimental — accuracy not yet measured
The Results report that all-cause dementia incidence increased with age among people aged 90 and older, and that 22% of examiner-diagnosed cases were vascular dementia. They do not report age-specific vascular dementia rates or compare their pattern with stroke. The separate claim about dementia after stroke in people under 80 is attached to citation 270, not this source. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [270] source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A recent study reporting on the prevalence of VaD in developing countries reported a range of 0.6% to 2.1%.3,33”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
- Supportedcites [3] source
The Vascular dementia section directly reports a VaD prevalence range of 0.6% to 2.1% in developing countries. It specifies that the estimates are for people aged over 65; the citing sentence omits that age qualifier. No page number is provided in our copy. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [33] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic hyperglycemia, increased insulin, the metabolic syndrome, and diabetes are associated with VCI,337,345–348 as well as VaD or dementia with stroke.349,350”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
What the sources say
- Not checked — no full text of the sourcecites [337] source
- Not checked — no full text of the sourcecites [345] source
- Not checked — no full text of the sourcecites [346] source
- Partly supportedcites [347] sourceExperimental — accuracy not yet measured
The Comment and Results (pages unavailable) link metabolic syndrome and high fasting glucose to cognitive impairment in older women. They do not establish an association specifically with vascular cognitive impairment (VCI), and the paper does not report an association for increased insulin. The citing sentence assigns its separate claim about vascular dementia or dementia with stroke to other citations. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [348] source
- Supportedcites [349] source
The citation to this paper is attached to the VaD or dementia-with-stroke part of the sentence, rather than the preceding VCI claim. The Discussion (page not specified) states that type 2 diabetes is associated with an increased risk of vascular dementia and discusses Alzheimer's disease with cerebrovascular disease. (LLM, conf=0.90)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Body mass index measured in midlife is more strongly associated with VCI, whereas body weight measured later in life has an inverse association with cognitive impairment, where obesity is associated with a lower risk of dementia.320”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
- Partly supportedcites [320] sourceExperimental — accuracy not yet measured
The Introduction says high BMI has been associated with dementia, and the Results report that women overweight or obese in midlife had a higher blood–brain barrier permeability measure 24 years later. The paper does not establish a stronger association specifically with vascular cognitive impairment (VCI), compare midlife BMI with later-life weight as predictors of cognitive impairment, or report that later-life obesity lowers dementia risk. The cited passages have no page numbers in our copy. (LLM, conf=0.83)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Physical activity may increase brain neurotrophins, such as brain-derived neurotrophic factor, improve cerebrovascular functioning and brain perfusion, reduce response to stress, and increase brain plasticity through synaptogenesis and neurogenesis.302”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
- Could not verifycites [302] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A recent review identified older age, lower education, prestroke cognitive impairment, diabetes, and atrial fibrillation as factors that increased the risk, but one of the strongest predictors of cognitive decline after an initial stroke was the occurrence of a second stroke.269,270”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.2. Stroke
What the sources say
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Specifically, reduced cardiac output has been associated with executive dysfunction (mainly sequencing and planning difficulties)381 and regional WMLs adjacent to the subcortical nuclei.382”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.6. Low Cardiac Output
What the sources say
- Could not verifycites [381] sourceExperimental — accuracy not yet measured
The Discussion mentions white matter lesions in relation to diabetes, but does not link them to cardiac output or locate them adjacent to subcortical nuclei. Searches for reduced cardiac output and regional white matter lesions found no passage addressing that association. Citation 382 is attached to the white-matter-lesion part of the citing sentence. (LLM, conf=0.76)
- Partly supportedcites [382] sourceExperimental — accuracy not yet measured
The Discussion reports that, among older adults with cardiovascular disease, reduced cardiac output was associated with executive dysfunction and white matter hyperintensities. It does not specify sequencing or planning difficulties, or locate the lesions adjacent to subcortical nuclei. The paper’s own Results found only a borderline association with a combined executive-function/information-processing score. (LLM, conf=0.86)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Management of vascular risks and symptomatic pharmacotherapy targeting VaD has been the primary approach.390”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.1. Background
What the sources say
- Supportedcites [390] source
The Primary and Secondary Prevention section describes treatment of vascular risk factors, while Pharmacotherapy in VaD reviews drugs studied for symptomatic treatment. The Conclusions bring these approaches together, emphasizing vascular-risk control and trials of symptomatic agents; the paper also cautions that no symptomatic VaD treatment was officially approved. (LLM, conf=0.86)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The importance of balanced nutrition in early life for normal neurocognitive development, a process that is not finished until late adolescence, has been widely recognized.427”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.1. Public Health Aspects
What the sources say
- Partly supportedcites [427] sourceExperimental — accuracy not yet measured
The Medical and Public Health Implications section links maternal nutrition and early development with the infant’s cognitive development, supporting the importance of early-life nutrition. It does not say that neurocognitive development continues until late adolescence; no page number is available in our copy. (LLM, conf=0.81)
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Cognitive rehabilitation and cognitive stimulation so far have not proven effective.419,420”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.4. Nonpharmacological Treatments
What the sources say
- Could not verifycites [419] sourceExperimental — accuracy not yet measured
The Methods and Results sections describe trials comparing vinpocetine with placebo, and the Discussion concludes that evidence for vinpocetine's benefit is inconclusive. Searches for cognitive rehabilitation, cognitive stimulation, and nonpharmacological interventions found no passage assessing whether either approach has proven effective. Page numbers were not available in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [420] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cognitive benefit was found, but global and functional efficacy was less consistent in the individual studies.396,400”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
- Could not verifycites [396] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) examines white matter hyperintensities and cognition, and says their effect on response to cholinesterase inhibitors remains to be determined. Searches for donepezil and for global and functional treatment outcomes found no passage assessing those outcomes in vascular dementia. (LLM, conf=0.75)
- Supportedcites [400] source
The Discussion reports a small but significant cognitive improvement in this trial, no difference on the global CIBIC-Plus measure, and consistency with two prior donepezil VaD trials. It also describes a variable effect on activities of daily living, supporting the claim that functional efficacy was less consistent. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Results of studies on blood pressure measured in late life and dementia are less consistent, with most finding no association with hypertension or an association with low blood pressure and dementia.343,428”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
What the sources say
- Not checked — no full text of the sourcecites [343] source
- Could not verifycites [428] sourceExperimental — accuracy not yet measured
The Common cause hypothesis and Reverse causality sections discuss cognitive ageing and illness in older people, but neither addresses blood pressure and dementia. Searches for late-life blood pressure, hypertension, and dementia found no passage reporting the claimed pattern of study results. (LLM, conf=0.74)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The treatment was found to have no effect on the risk of dementia or cognitive decline.444”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
What the sources say
- Partly supportedcites [444] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says HYVET-COG confirmed a non-significant reduction in dementia risk, which supports a finding of no statistically significant effect—not proof of no effect. It does not report HYVET-COG's cognitive-decline result; the no-difference finding for cognitive decline in the Discussion concerns PRoFESS patients instead. (LLM, conf=0.86)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In 3 studies there was no association between hypertension treatment and risk of Alzheimer disease,432–434 whereas in others there was a decreased risk of Alzheimer disease among those receiving antihypertensive treatment.429,431,435–437”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
What the sources say
- Not checked — no full text of the sourcecites [432] source
- Supportedcites [433] source
The citation supports the decreased-risk part of the sentence, not the finding attributed to the three other studies. In the Results (Table 2), participants treated for more than 12 years had lower Alzheimer disease risk than never-treated hypertensive participants; the shorter-treatment groups did not show a clear reduction. Page numbers were not provided in the passages. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [434] source
- Not checked — no full text of the sourcecites [429] source
- Not checked — no full text of the sourcecites [431] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“It was concluded that cognitive dysfunction is an independent predictor of clinical outcomes in patients with type 2 diabetes mellitus but does not modify the effects of blood pressure lowering or glucose control on the risk of major cardiovascular events.458”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.4. Diabetes
What the sources say
- Could not verifycites [458] sourceExperimental — accuracy not yet measured
The Background lists diabetes as a possible baseline risk factor, but the Discussion addresses whether blood-pressure lowering prevents cognitive decline or dementia in hypertensive patients without prior cerebrovascular disease. Searches for the claimed independent prediction and for glucose control and major cardiovascular events found no passage addressing those findings in patients with type 2 diabetes. (LLM, conf=0.76)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Treatment with statin therapy has been documented to protect against stroke, both in primary460 and secondary studies, based on data from meta-analysis36 and a single trial, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL).461”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.5. Lipids
What the sources say
- Not checked — no full text of the sourcecites [460] source
- Not checked — no full text of the sourcecites [36] source
- Could not verifycites [461] sourceExperimental — accuracy not yet measured
The Introduction (p. 2) describes ADVANCE as studying blood-pressure lowering and intensive glucose control, and the Discussion (p. 7) discusses stroke in relation to blood-pressure treatment. Searches for statins, SPARCL, and meta-analysis found no passage in our copy addressing the claimed protection against stroke in primary or secondary studies. (LLM, conf=0.76)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“A few observational studies have documented that people who consume a Mediterranean diet have better cognition and less risk of dementia than people consuming other diets.470”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.6. Other Interventions for Vascular Factors
What the sources say
- Could not verifycites [470] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) discusses observational findings about NSAID use and Alzheimer’s risk, not Mediterranean diets. Searches for “Mediterranean diet” and “diet cognition dementia risk” found no passage in our copy addressing diet, cognition, or a dietary comparison. (LLM, conf=0.76)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“These studies had variable methods in relation to model type (fixed or random) and selection of patients.453,454”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
What the sources say
- Could not verifycites [453] sourceExperimental — accuracy not yet measured
The Subjects and Methods section describes statistical analyses of the Syst-Eur trial, not a comparison of meta-analyses. Searches for fixed versus random models, patient selection, and meta-analysis found no passage in our copy addressing the claimed variation in methods. Page numbers were not available in the indexed passages. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [454] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“For example, in a cohort in Finland, the combination of elevated systolic blood pressure, hypercholesterolemia, and obesity increased the risk of Alzheimer disease by ≈6 times, whereas individually, any of these factors alone increased risk by ≈2 times.494”
§ Vascular Contributions to Cognitive Impairment and Dementia > 12. Summary and Course of Action
What the sources say
- Could not verifycites [494] sourceExperimental — accuracy not yet measured
Subjects and Methods (p. 2) describes a Finnish cohort of patients with ischemic stroke, while the Discussion (p. 4) compares criteria for diagnosing vascular dementia. Our copy does not address Alzheimer disease risk from the specified combination of blood pressure, cholesterol, and obesity, or report the claimed sixfold and twofold increases (searched those factors and risk estimates). (LLM, conf=0.78)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Could not verify
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Carotid intimal-medial thickness and arterial stiffness are emerging as markers of arterial aging and may serve as risk markers for VCI.”
§ Vascular Contributions to Cognitive Impairment and Dementia > Abstract > Results
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear? Based: unclearIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The neuropathology of cognitive impairment in later life is often a mixture of Alzheimer disease and microvascular brain damage, which may overlap and synergize to heighten the risk of cognitive impairment.”
§ Vascular Contributions to Cognitive Impairment and Dementia > Abstract > Results
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Dementia criteria based on memory deficits are derived from concepts proposed for Alzheimer disease, but these may not be suitable for the dementia syndrome associated with cerebrovascular disease, in which memory-related structures (eg, mesial temporal lobe, thalamus) could be intact, resulting in relatively preserved memory functions.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.2. Clinical Criteria for the Diagnosis of VaD
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Vascular contributions to cognitive impairment and dementia of later life are common.”
§ Vascular Contributions to Cognitive Impairment and Dementia > Abstract > Background and Purpose
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These risks may include but are not limited to atrial fibrillation, hypertension, diabetes mellitus, and hypercholesterolemia.”
§ Vascular Contributions to Cognitive Impairment and Dementia > Abstract > Results
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As the threshold is expanded, the frequency rates increase accordingly.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 1. Introduction
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“This synergistic effect between Alzheimer disease and cerebrovascular disease pathology may explain why patients with mesial temporal lobe atrophy, presumably attributable to Alzheimer disease, have an increased risk of dementia after stroke compared with those without atrophy, because hippocampal atrophy may also be caused by vascular disease.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.3. Heterogeneity of the VaD Syndrome
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“All of the major criteria for VaD have a different definition of dementia, and this results in challenges in reliability studies.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.2. Clinical Criteria for the Diagnosis of VaD
What the sources say
- Not checked — no full text of the sourcecites [26] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Furthermore, these same vascular risk factors may be risk markers for Alzheimer disease.”
§ Vascular Contributions to Cognitive Impairment and Dementia > Abstract > Results
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although some authors propose that the symptoms should appear within 3 months after a stroke,30 this is arbitrary, and symptoms may develop after this time frame.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.2. Clinical Criteria for the Diagnosis of VaD
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Currently, no specific treatments for VCI have been approved by the US Food and Drug Administration.”
§ Vascular Contributions to Cognitive Impairment and Dementia > Abstract > Results
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Some studies contend that mixed pathologies, including the degenerative components caused by Alzheimer disease and vascular factors, are the most common explanation for cognitive impairment in aging.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 1. Introduction
What the sources say
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Formal search strategies, however, were used as indicated for evaluation of clinical trial information.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 1. Introduction
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Some of the literature review was based on the expert panel's knowledge of the field and therefore may be subject to bias.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 1. Introduction
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Importantly, consensus-based recommendations for standardized imaging, cognitive, and pathological protocols have been developed.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 1. Introduction
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“the more liberal criteria for VaD proposed by Hachinski et al result in large numbers, whereas the more conservative criteria such as those of the National Institute of Neurological Disorders and Stroke–Association Internationale pour la Recherché et l'Enseignement en Neurosciences (NINDS-AIREN) yield more modest rates.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 1. Introduction
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Understanding of VCI has evolved substantially in recent years, based on preclinical, neuropathologic, neuroimaging, physiological, and epidemiological studies.”
§ Vascular Contributions to Cognitive Impairment and Dementia > Abstract > Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Indeed, although Tomlinson et al described 100 mL of tissue loss as sufficient for dementia, those with lesser volumes of loss also had dementia.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.2. Cerebral Infarctions and VCI
What the sources say
- Not checked — no full text of the sourcecites [51] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“these behaviors (depression or depressive symptoms) can severely influence patients’ activities of daily living and cognitive performance, although some symptoms can revert with treatment (eg, depression), and consequently cognition can improve.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.5. Reversibility of VaMCI
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, determining the volume or number necessary for VCI or dementia has proved difficult, and unlike with Alzheimer disease and other neurodegenerative diseases, there are no currently accepted neuropathological criteria to confirm a clinical diagnosis of VCI.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.2. Cerebral Infarctions and VCI
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In clinical-pathological studies, larger volumes39,51 and an increased number11,13,39,55,56 of macroscopic infarcts are as sociated with an increased likelihood of dementia.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.2. Cerebral Infarctions and VCI
What the sources say
- Not checked — no full text of the sourcecites [39] source
- Not checked — no full text of the sourcecites [51] source
- Not checked — no full text of the sourcecites [11] source
- Not checked — no full text of the sourcecites [13] source
- Not checked — no full text of the sourcecites [55] source
- Not checked — no full text of the sourcecites [56] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“For decades it has been recognized that cerebrovascular disease is associated with dementia”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“This research area is complicated by the difficulty of clinically differentiating Alzheimer disease or VCI from mixed (Alzheimer disease plus cerebrovascular disease) disease, which may be more common than either “pure” Alzheimer disease or “pure” VCI.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 2. Defining Alzheimer Disease and VCI > 2.6. Neuropsychological Assessments of VCI
What the sources say
- Not checked — no full text of the sourcecites [9] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas primary vessel disease may be associated with focal (eg, infarct) or diffuse tissue damage (eg, white matter degeneration) or may result in nonmorphologic functional changes.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.5. Other Vascular Pathologies
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.3. Relation of Infarcts to Alzheimer Disease Pathology and Dementia
What the sources say
- Not checked — no full text of the sourcecites [16] source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Vascular and degenerative pathologies are 2 common disorders in later life and often coexist”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.7. Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The interplay between macroscopic and microscopic infarcts and other vascular and degenerative pathologies in the development of clinical Alzheimer disease and VCI is complex.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.7. Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and each separately adds to the likelihood of cognitive impairment and dementia.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.7. Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, vascular and degenerative pathologies may result in overlapping clinical and imaging phenotypes.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 3. Neuropathological Aspects > 3.7. Summary
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“loss of energy-saving saltatory conduction increases metabolic demands and enhances local energy deficit and hypoxia.128”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation
What the sources say
- Not checked — no full text of the sourcecites [128] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.2. The Neurovascular Unit: A Target of Vascular and Neurodegenerative Dementias
What the sources say
- Not checked — no full text of the sourcecites [113] source
- Not checked — no full text of the sourcecites [114] source
- Not checked yetcites [115] source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites [116] source
- Not checked — no full text of the sourcecites [117] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Plasma Aβ, which is elevated in some patients with VCI and Alzheimer disease, induces cerebrovascular insufficiency and could play a role in the white matter alterations observed in both conditions.130,131”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Although free radicals can induce inflammation by activating redox-sensitive proinflammatory transcription factors, the endothelial dysfunction induced by oxidative stress can release vascular endothelial growth factor and prostanoids, which promote vascular leakage, protein extravasation, and cytokine production.125”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation
What the sources say
- Not checked — no full text of the sourcecites [125] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“in Alzheimer disease and CAA, accumulation of Aβ in the media of cortical arterioles weakens the vessel wall and increases the chance of lobar hemorrhages.109”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.2. The Neurovascular Unit: A Target of Vascular and Neurodegenerative Dementias
What the sources say
- Not checked — no full text of the sourcecites [109] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Arterioles exhibit signs of “onion skin”–type changes and undergo hyaline degeneration (lipohyalinosis), a cause of microhemorrhages.105”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.2. The Neurovascular Unit: A Target of Vascular and Neurodegenerative Dementias
What the sources say
- Not checked — no full text of the sourcecites [105] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In models of autoimmune white matter injury, extravasation of plasma protein triggers vascular inflammation and axonal demyelination,127 which in turn disrupts saltatory conduction,128 slowing the transmission of nerve impulses.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“CAA appears in ≈10% to 30% of unselected brain autopsies and 80% to 100% when in the presence of accompanying Alzheimer disease.136”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.1. Cerebral Amyloid Angiopathy and Vascular Effects of Aβ
What the sources say
- Not checked — no full text of the sourcecites [136] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Diagnostic approaches to CAA (and to CADASIL, the most common form of hereditary small-vessel disease) have improved, but no disease-modifying therapies have been identified.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.3. Summary
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Vascular oxidative stress and inflammation underlie many of these deleterious effects and are potential therapeutic targets.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.5. Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
In the paper
“Although there are relatively few animal models of cognitive impairment and white matter damage, models recapitulating features of CAA, CADASIL, cerebral hypoperfusion, and hypertensive vasculopathy have been developed, mainly in rodents.5”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.4. Animal Models of VCI
What the sources say
- Not checked — no full text of the sourcecites [5] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“They include carotid wall thickening and aortic stiffening, which also likely reflect atherosclerosis and arteriosclerosis, respectively.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear? Based: unclearIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neurovascular dysfunction increases the brain's susceptibility to injury by (a) altering regulation of the cerebral blood supply, (b) disrupting BBB function, and (c) reducing the trophic support and repair potential of the injured brain.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.5. Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“This disorder can present clinically as migraines with aura, mood disturbances, recurrent strokes, or cognitive impairment163 and radiographically by the appearance of extensive WMLs, lacunar infarcts, microbleeds, and brain atrophy.164”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.2. Hereditary Small-Vessel Syndromes
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“CAA can also trigger vascular or perivascular inflammation,150,151 manifesting as vasogenic edema of subcortical white matter and more rapidly progressive cognitive decline.152”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.1. Cerebral Amyloid Angiopathy and Vascular Effects of Aβ
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Rodent models, although well suited to genetic manipulations and large-scale studies, can be problematic because of their small amount of white matter and limited behavioral repertoire.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 4. Basic Science Aspects: Importance of the Neurovascular Unit and Cerebral Blood Flow > 4.4. Animal Models of VCI
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“T2*-weighted gradient-echo MRI sequences provide substantially increased sensitivity for detection of cerebral microbleeds and are key to the diagnosis of probable CAA.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.1. Cerebral Amyloid Angiopathy and Vascular Effects of Aβ
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Other hereditary small-vessel syndromes of the brain are rare and have generally not been reported as causes of sporadic disease via de novo mutation.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 5. Cerebral Amyloid Angiopathy and Hereditary Small-Vessel Syndromes > 5.2. Hereditary Small-Vessel Syndromes
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Central systolic blood pressure and pulse pressure can be estimated noninvasively either from the radial artery waveform, using a transfer function, or from the common carotid waveform.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.2. Arterial Stiffness and VCI
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Furthermore, the relative contributions to VCI of microbleeds seen on MRI or microinfarcts discovered at autopsy remain uncertain, although both occur with increased frequency among people diagnosed with dementia during life.77,233”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.1. Clinical Presentation and Importance of Neuroimaging Studies
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Carotid IMT can reflect either a media thickening in response to the increase in blood pressure in hypertensive patients, an intima thickening in response to atherosclerotic risk factors, or most often a combination of both.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.1. Carotid Intima-Media Thickness and VCI
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In all likelihood, common cardiovascular factors influence both IMT and VCI independently, but the consequences of vascular disease may also directly affect cognitive function.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.1. Carotid Intima-Media Thickness and VCI
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Both aortic pulse wave velocity and central systolic blood pressure and pulse pressure predict cardiovascular events independent of classic cardiovascular risk factors.182”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.2. Arterial Stiffness and VCI
What the sources say
- Not checked — no full text of the sourcecites [182] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Small-vessel disease increases with age and is accelerated by vascular risk factors, most notably, hypertension and diabetes.223”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.3. Small-Artery Remodeling and VCI
What the sources say
- Not checked — no full text of the sourcecites [223] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As previously discussed, VCI may have a variety of clinical presentations that may depend on the setting in which patients are evaluated.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.1. Clinical Presentation and Importance of Neuroimaging Studies
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The analysis of aortic pressure waveform allows the calculation of central systolic blood pressure and pulse pressure, which are influenced by aortic stiffness and the geometry and vasomotor tone of small arteries.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 6. Pathophysiology of Arterial Structure and Function > 6.2. Arterial Stiffness and VCI
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Left hemisphere, anterior and posterior cerebral artery distribution, multiple infarcts, and strategic infarcts have been associated with PSD in at least 2 studies.40”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.3. Poststroke Dementia
What the sources say
- Not checked — no full text of the sourcecites [40] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Conversely, measures of cerebral gray matter and hippocampal volume were both associated with declines in memory performance.256”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.4. CVBI and Cognition in Convenience Samples
What the sources say
- Not checked — no full text of the sourcecites [256] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“WMLs also share risk factors with stroke,239 although advancing age remains a strong effect.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Not checked — no full text of the sourcecites [239] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Among neuroimaging findings, silent cerebral infarcts, white matter changes, and global and medial temporal lobe atrophy are associated with increased risk of PSD.252”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.3. Poststroke Dementia
What the sources say
- Not checked — no full text of the sourcecites [252] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Patients with PSD have degrees of functional impairment and high mortality rates.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.3. Poststroke Dementia
What the sources say
- Not checked — no full text of the sourcecites [252] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In a Rochester, MN, community-based study of stroke, the prevalence of dementia was 30% immediately after stroke, and the incidence of new-onset dementia increased from 7% after 1 year to 48% after 25 years.250”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.3. Poststroke Dementia
What the sources say
- Not checked — no full text of the sourcecites [250] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“WMLs are even more common and are generally present in most people >30 years of age,231 increasing steadily in extent with advancing age.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.2. Prevalence of CVBI and Associated Cognitive Findings
What the sources say
- Not checked — no full text of the sourcecites [231] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Risk of dementia is higher with increased age and fewer years of education, history of diabetes mellitus and atrial fibrillation, and recurrent stroke.251”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.3. Poststroke Dementia
What the sources say
- Not checked — no full text of the sourcecites [251] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Prevalence estimates of VaD vary widely.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In general, however, after age 65 years, there is an exponential increase in prevalence and incidence of VaD as age increases,265,266 although the trends after 90 years of age have not been well established.4,267,268”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The clinical presentation and course of CVBI are highly variable, with the classic phenotype of stepwise decline in association with stroke10 being a relatively uncommon presentation for VCI.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.6. Summary
What the sources say
- Not checked — no full text of the sourcecites [10] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Structural MRI provides a fairly sensitive and specific marker for CVBI, but the relationship between CVBI and cognitive impairment is confounded by the frequent presence of Alzheimer disease changes of the brain and co-occurrence of depression on a cerebrovascular basis.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 7. Neuroimaging Factors That May Influence the Clinical Presentation and Course of VCI > 7.6. Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Antioxidants, which include vitamins E,282 C, and beta carotene,283 consumed either as a part of the diet (fruits and vegetables) or as supplements, have been reported to reduce the risk of cognitive impairment.284”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Some studies report a higher incidence of VaD in men than in women,4,271 although a pooled analysis of incidence studies found no difference.272”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Fish oil n-3 polyunsaturated fatty acids are of interest because of their antioxidant and antiinflammatory properties and because they are major components of membrane phospholipids in the brain and play a critical role in neuronal function.288”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
- Not checked — no full text of the sourcecites [288] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The apolipoprotein E ε4 allele is associated with increased levels of cardiovascular risk factors276 and is a strong indicator of genetic risk for Alzheimer disease.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
- Not checked — no full text of the sourcecites [276] source
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“MCI may not differ by sex,273 but additional studies are needed to answer this question.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
- Not checked — no full text of the sourcecites [273] source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“The incidence of VaD appears to be higher in blacks than in whites4 or in Hispanics with a history of stroke,274 possibly reflecting group differences in cerebrovascular risk profile.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.1. Nonmodifiable Risk Factors
What the sources say
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, there are a number of possible explanations or confounders in relation to education level and VCI.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“We recognize that this is a somewhat arbitrary choice, because many articles and reviews show that vascular risk factors are also importantly associated with Alzheimer disease, mixed dementia, and amnestic MCI.110,260,261”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline
What the sources say
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Findings from these prospective cohort studies for diastolic blood pressure and cognitive decline are less consistent; however, many have reported a similar inverse relation.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In longitudinal cohort studies, higher systolic blood pressure has been associated with greater late-life cognitive decline, although some studies have reported a J- or U-shaped relation.342”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
What the sources say
- Not checked — no full text of the sourcecites [342] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The data on the role of blood pressure and hypertension in later life are not consistent, leaving open the issue of blood pressure treatment in older people.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, studies vary in the amount of alcohol associated with a positive effect; the relative significance of global, memory, and executive function; and whether the effect varies by sex.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“possibly because nicotine may also stimulate cholinergic pathways within the brain.326”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
- Not checked — no full text of the sourcecites [326] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There is a relative paucity of data on the type and frequency of physical activity and what the short- and long-term benefits of physical activity are for preservation of brain health.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“However, long-term regular physical activity, including vigorous activity and walking, was strongly associated with higher levels of cognitive function, less cognitive decline, and less VaD.303–306”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.2. Lifestyle Factors
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Depression may impact cognitive functions and may mimic cognitive decline.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.3. Depression
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Midlife systolic and diastolic blood pressure, history of hypertension, and total cholesterol level predict VCI.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In the Finnish study Cardiovascular Risk Factors Aging and Dementia (CAIDE), midlife measures of total cholesterol significantly predicted cognitive impairment 21 years later, an association that was attenuated after accounting for statin therapy.354”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
What the sources say
- Not checked — no full text of the sourcecites [354] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Severe chronic kidney disease has been associated with metabolic (uremic) and hypertensive encephalopathy and an increased risk of stroke.366”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.3. Chronic Kidney Disease
What the sources say
- Not checked — no full text of the sourcecites [366] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings have been reported across multiple populations.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Findings in late-life cohorts vary, with some finding higher levels of cholesterol associated with a lower risk356 and others finding a higher risk for VaD.357”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There are scarce data relating flow-mediated endothelial dilatation (brachial artery reactivity) with cognition.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.5. Peripheral Arterial Disease
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Some of these differences could be related to age or sex (the effect was weaker in women and older people) and the administration and effectiveness of anticoagulation.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.4. Atrial Fibrillation
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The relation of late-life VCI to measures of blood pressure and cholesterol in later life remains uncertain and requires further study, although higher levels of exposure to these risk factors may prove to be beneficial.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As with blood pressure, inconsistencies may reflect timing of the cholesterol measurements relative to age, older people possibly being less likely to receive lipid-lowering therapy (“generational effect”), and clinical onset of dementia.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 8. Impact of Cardiovascular Risk Factors at Different Ages on the Risk of Cognitive Decline > 8.4. Physiological Risk Factors
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Coronary artery bypass graft has been associated with poorer initial cognitive function and a higher late-life dementia risk.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.1. Coronary Artery Disease
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Many facets of dementia care do not involve therapies directed at disease modification.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.1. Background
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Cochrane reviews of VaD trials concluded that donepezil studies have provided the best available evidence for a beneficial effect for VaD397 and galantamine for mixed states,402 whereas a benefit of memantine410 and rivastigmine is still not proven.404”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“A subsequent study of “pure” VaD patients (n=788) showed cognitive treatment benefits, including benefit for an executive measure but not for daily functions; however, there was an overall trend for global benefit (P=0.06).401”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
- Not checked — no full text of the sourcecites [401] source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Over the past decade, the role of vascular brain disease as a cause of cognitive impairment has become increasingly evident, alone or combined with Alzheimer disease.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.1. Background
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“In a recent study, however, more deaths occurred in the donepezil treatment group; this was attributed to the less than expected death rate in the placebo group.398”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
- Not checked — no full text of the sourcecites [398] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The timing of such interventions may be important, because the association with dementia appears to be stronger for vascular factors and when measured in midlife rather than in old age, which suggests that midlife may be a critical period.424”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.1. Public Health Aspects
What the sources say
- Not checked — no full text of the sourcecites [424] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“An 18-week study of donepezil in 168 patients with CADASIL had a neutral result but showed benefit in executive function measures in secondary analysis.408”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
- Not checked — no full text of the sourcecites [408] source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This finding suggests that hippocampal volume may need to be accounted for in future VaD trials.398”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
- Not checked — no full text of the sourcecites [398] source
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In an analogous manner, disease of the coronary or peripheral arterial circulations, atrial fibrillation, and clinically detectable renal and cardiac failure have each been associated with cognitive impairment.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.7. Summary: Concomitant Disease
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“There was statistically significant less decline in cognition, function, and behavior with galantamine, driven by the mixed subgroup, whereas subjects treated with placebo showed decline.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
- Not checked — no full text of the sourcecites [403] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Vascular and metabolic risk factors should therefore be regarded as potential major targets for the prevention of dementia.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.1. Public Health Aspects
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence.
In the paper
“It has been estimated, for example, that among the 106 million cases of Alzheimer disease expected worldwide by the year 2050, ≈23 million could be avoided completely if it were possible to delay the onset of disease by 2 years.423”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.1. Public Health Aspects
What the sources say
- Not checked — no full text of the sourcecites [423] source
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although this is caused in part by loss of brain tissue, it may also reflect a direct effect of vascular risk factors on both risk of stroke and cognitive function.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 9. Concomitant Clinical Vascular Disease > 9.7. Summary: Concomitant Disease
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“One meta-analysis commented that the cognitive benefits of cholinergic agents and memantine were of uncertain clinical significance in VaD, and more data are required before widespread use of these agents is to be considered.411”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
- Not checked — no full text of the sourcecites [411] source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specific pharmacotherapy trials targeting VaD have shown consistent, modest cognitive improvements with donepezil, galantamine, and memantine, but functional and global benefits have been less consistent, with evidence only from 2 large donepezil trials.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.3. Summary and Recommendations: Pharmacological Therapy
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, there are few randomized controlled trials, and there are methodological limitations in existing studies in the area.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.4. Nonpharmacological Treatments
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The donepezil trials focused on “pure” VaD (n=1219), in which placebo groups were stable over 6 months, requiring improvement to show efficacy.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
Strength:plain· not yet calibratedn = 1,219Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Nonpharmacological approaches have also been tried.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.1. Background
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Rivastigmine has been less well studied, but beneficial effects on an executive measure were found in a 22-month, open-label controlled (n=16) study409 and in a double-blind placebo-controlled trial targeting vascular cognitive impairment, no dementia (n=50).405”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.2. Pharmacological Treatment of Cognitive Impairment
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Mean duration of follow-up was ≤5 years for most studies, except 2 studies with a follow-up of 13429 and 19430 years and that included participants who were a younger age at inclusion.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Acupuncture showed cognitive benefit in a rodent model of VaD,421 but a Cochrane review of acupuncture in human VaD was inconclusive,422”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.4. Nonpharmacological Treatments
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Reasons include only modest benefit on standard cognitive measures, which undersampled executive functioning”
§ Vascular Contributions to Cognitive Impairment and Dementia > 10. Clinical Trials in VCI and Symptomatic Treatment > 10.1. Background
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During the 4-year follow-up, dementia was diagnosed in 410 patients, of whom 108 had dementia preceded by a stroke.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Strength:plain· not yet calibratedn = 410Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By comparing angiotensin receptor blockers with an angiotensin-converting enzyme inhibitor, 2 classes of drug similar in novelty and price, this study is a remarkable attempt to overcome confounding by indication.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the extension study, both Alzheimer disease and VaD were reduced by treatment with nitrendipine.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings, however, were based on a limited follow-up, a relatively small number of dementia cases, and confounding by indication.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the follow-up was relatively short, and ethnic disparities were not assessed.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The trial was stopped prematurely after a median follow-up period of 2 years on evidence of significant benefits from treatment with nitrendipine for lowering the risk of stroke.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“(4) small numbers of incident cases and low statistical power;”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The use of administrative databases, however, is subject to limitations such as a lack of precision concerning diagnosis of dementia and Alzheimer disease or the impossibility of taking into account potential major confounders such as educational level.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Although initially planned as a trial of an angiotensin receptor blocker versus placebo, during the trial and for ethical reasons, antihypertensive drugs were administered to patients in the control group. Therefore, between-group blood pressure differences and the study power were reduced.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Combination therapy reduced systolic and diastolic blood pressure by 12 and 5 mm Hg, respectively, and stroke risk by 43%.451”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
What the sources say
- Not checked — no full text of the sourcecites [451] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Interestingly, 2 analyses of the same study showed different results according to the duration of follow-up: no effect on dementia and Alzheimer disease in a first study with only 2.2 years of follow-up432 and a 5% reduction in risk of dementia per year of treatment (6% for Alzheimer disease) in a study with a much longer follow-up.429”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Longer duration of treatment and lower age were associated with a stronger protective effect.429”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
What the sources say
- Not checked — no full text of the sourcecites [429] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A few studies suggest a greater effect of some classes of antihypertensive therapy, but the evidence remains limited and is subject to bias so that no firm conclusion can be drawn about this relationship.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.2. Results of Main Studies on Vascular Factor Control and the Prevention of Dementia
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Some observational studies have suggested a beneficial effect of aspirin on cognition,465,466 although this was not confirmed in others.467,468”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.6. Other Interventions for Vascular Factors
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Patients with diabetes of long duration are at increased risk of cognitive decline, dementia, and depression, as well as other phenotypes associated with aging.438a”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.4. Diabetes
What the sources say
- Not matchedcites 438a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Diabetes is an important risk factor for mental symptoms and cognitive impairment, but available data are based mostly on observational studies.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.4. Diabetes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“They are subject to limitations similar to those of therapeutic trials and do not yield any substantial additional information.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There is generally a lack of evidence for a positive benefit of antiaggregants and vitamin supplementation on cognitive function.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.6. Other Interventions for Vascular Factors
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Only 1 trial found that the risk for dementia was significantly decreased, but it was embedded in the report of the HYVET results, and its description was scant, especially concerning selection criteria for the studies.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This is often accompanied by other disturbances of mental function, such as depression or anxiety, all of these conditions being described as being more prevalent in established type 2 diabetes mellitus.438a”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.4. Diabetes
What the sources say
- Not matchedcites 438a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There is scant evidence from observational studies on the effects of statin therapy on cognitive function, and the level of evidence is low.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.5. Lipids
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Observational studies point to some benefit of antihypertensive treatment on the risk for Alzheimer disease, the treatment being apparently more effective in the youngest old than in the oldest people.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The treatment of hyperglycemia is associated with prevention of both microvascular and, to some degree, macrovascular events, based on data from a recent meta-analysis.457”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.4. Diabetes
What the sources say
- Not checked — no full text of the sourcecites [457] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The possible effect of intensive control–induced hypoglycemia on cognitive function represents a relevant and yet-to-be-explored aspect in older people with diabetes.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.4. Diabetes
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In severe cases of hyperglycemia, the cognitive dysfunction is acutely impaired by hyperosmolar influences and electrolyte disturbances, conditions that are possible to improve by acute insulin therapy.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.4. Diabetes
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although lipid control by statin therapy is able to prevent stroke, these drugs do not prevent cognitive decline in the elderly.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.5. Lipids
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Meta-analyses neither prove nor disprove the efficacy of antihypertensive treatment on the risk of dementia.”
§ Vascular Contributions to Cognitive Impairment and Dementia > 11. Prospects for Prevention of VCI and Alzheimer Disease by Risk Factor Control > 11.3. Clinical Trials of Blood Pressure–Lowering Drugs and Risk of Dementia
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Therefore, it has been proposed that there may be a convergence of pathogenic mechanisms in vascular and neurodegenerative processes that cause impairment of cognition.101,493”
§ Vascular Contributions to Cognitive Impairment and Dementia > 12. Summary and Course of Action
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In fact, there is an angiogenesis hypothesis for Alzheimer disease and a possible role for genes in neurovascular unit dysfunction in Alzheimer disease.107,492”
§ Vascular Contributions to Cognitive Impairment and Dementia > 12. Summary and Course of Action
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In addition, as subclinical CVBI, stroke, and vascular risk factors have been a major focus of this statement, a better understanding of the prevention of “silent” strokes and WMLs (ie, “covert” brain injury) is necessary, because these events may be associated with neuropsychological deficits and contribute to VCI and eventual manifest stroke sequelae risk.498”
§ Vascular Contributions to Cognitive Impairment and Dementia > 12. Summary and Course of Action
What the sources say
- Not checked — no full text of the sourcecites [498] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Silent strokes outnumber clinically manifest strokes by more than nine to one.
- Rests on an assumption: The proportion of people with milder VCI is about twice that with severe VCI (VaD).
The authors state this as an assumption.
The underlying neuropathological substrate of amnestic mild cognitive impairment is pure Alzheimer disease pathology rather than vascular or mixed pathology.
“assuming the underlying neuropathological substrate of amnestic MCI is pure Alzheimer disease pathology rather than vascular or mixed pathology”
The paper relies on this without support.
Neuroimaging detects macroscopic infarcts about 3 mm or more in size, but microscopic infarcts and small-vessel disease are currently not within the resolution of most scans.
“First, neuroimaging detects macroscopic infarcts, ≈3 mm or more in size, but microscopic infarcts and small-vessel disease (eg, arteriolosclerosis) are currently not within the resolution of most scans.”
The paper relies on this without support.
Stiffer large arteries are associated with increased left ventricular mass.
“Additionally, stiffer large arteries are associated with increased left ventricular mass.”
The paper relies on this without support.
No study has investigated the relationship between small-artery remodeling and cognitive decline or white matter lesions.
“To the best of our knowledge, no study has investigated the relationship between small-artery remodeling and cognitive decline or WMLs.”
The paper relies on this without support.
In community-based studies, evidence of CVBI and cognitive impairment is often found without a history of a strokelike event.
“For example, in community-based studies, evidence of CVBI and cognitive impairment is often found without a history of a strokelike event.”
The paper relies on this without support.
Late-life depression may be accompanied by a higher frequency of brain white matter damage and other subcortical lesions, such as lacunar infarcts.
“There may be a higher frequency of brain white matter damage and other subcortical lesions, such as lacunar infarcts.”
The paper relies on this without support.
Depression with a cerebrovascular basis may respond to treatment with certain selective serotonin-reuptake inhibitors.
“Depression with a cerebrovascular basis may respond to treatment with certain selective serotonin-reuptake inhibitors.”
The paper relies on this without support.
The activity of biomarkers in the brain generally cannot be measured directly.
“The activity of biomarkers in the brain generally cannot be measured directly.”
The paper relies on this without support.
The only clear risk for cognitive impairment from alcohol intake is heavy alcohol use.
“The risks and benefits of alcohol intake have been debated for years, with the only clear risk for cognitive impairment being heavy alcohol use.”
The paper relies on this without support.
Smoking's effects on the cardiovascular system and neurons are mediated generally by oxidative stress and inflammation.
“Smoking has well-known effects on the cardiovascular system and neurons, which are mediated generally by oxidative stress and inflammation.”
The paper relies on this without support.
Inflammation is a key process linking many cardiovascular risk factors to vascular and neuronal damage.
“Inflammation is a key process linking many cardiovascular risk factors to vascular and neuronal damage.”
The paper relies on this without support.
During midlife, the population-attributable risk of dementia is highest for hypertension, up to 30% of late-life dementia cases.
“In relation to the role of vascular risk factors, during midlife the population-attributable risk of dementia has been reported to be highest for hypertension (up to 30% of cases of late-life dementia).”
The paper relies on this without support.
Smoking is a risk factor for stroke-associated dementia.
“Smoking is a risk factor for stroke-associated dementia.”
The paper relies on this without support.
Hyperlipidemia or dyslipidemia is a metabolic condition of importance for cognitive function.
“Hyperlipidemia or dyslipidemia is a metabolic condition of importance for cognitive function.”
The paper relies on this without support.
Cognitive function is an important predictor of morbidity and mortality in the elderly.
“Cognitive function, an important predictor of morbidity and mortality in the elderly, however, is frequently not screened for in clinical practice as part of global cardiovascular risk and target-organ damage assessments.”
The paper relies on this without support.
Silent strokes outnumber clinically manifest strokes by more than nine to one.
“It is estimated that “silent” strokes outnumber clinically manifest ones by a factor of >9:1”
The paper relies on this without support.
The proportion of people with milder VCI is about twice that with severe VCI (VaD).
“and the proportion of those with a milder form of VCI is approximately 2-fold greater than those with a severe form of VCI (ie, VaD).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“neither include advances in understanding the pathophysiology and measurement of SVD”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As pointed out by Gorelick et al. [56], a comprehensive assessment strategy is necessary for examining vascular contributions to subtle cognitive impairment, MCI, and dementia; and it notably differs from those strategies expressed by McKhann et al. [6] that bedside mental status testing—though not optimal—is acceptable or by the DSM-5 which recommends cognitive impairment be assessed either by”
From Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates (2014) · cites this paper as [56]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“one MVL identified in standard sections of brain (Table 1 regions shaded green) is of unclear relationship to cognitive function, while multiple MVLs in these regions are associated with increased likelihood of cognitive impairment or dementia [24,52,62].”
From National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2012) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“one MVL identified in standard sections of brain (Table 1 regions shaded green) is of unclear relationship to cognitive function, while multiple MVLs in these regions are associated with increased likelihood of cognitive impairment or dementia [24,52,62].”
From National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2012) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“included a class 2 recommendation for neuroimaging as part of the clinical investigation of vascular cognitive impairment.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“neither of these guidelines provide comprehensive recommendations for the many forms of SVD seen on neuroimaging”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“a scientific statement from the American Heart Association incorporated neuroimaging evidence for SVD or stroke as part of the criteria for probable vascular mild cognitive impairment and dementia”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
In the citing paper
“Furthermore, macroscopic infarcts occur in about one third to one half of elderly individuals, and of all major cognitively impairing disorders, including AD, there is a vascular component in up to 80%.4,18,19”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
In the citing paper
“Modifiable risks associated with poor cardiovascular health such as uncontrolled hypertension, diabetes mellitus, obesity, physical inactivity, smoking, and depression are associated with compromised brain health.4”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
In the citing paper
“The statement did not recommend changes to the current management of cardiovascular risk factors to prevent dementia”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
In the citing paper
“The only Class I recommendation was, “In people at risk for vascular cognitive impairment, treatment of hypertension is recommended.”4”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
In the citing paper
“Vascular dementia (VaD), the second most common cause of dementia after Alzheimer's disease (AD), accounts for at least 20% of cases. 3”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
In the citing paper
“Vascular dementia is now recognized as the second most common form of dementia after Alzheimer's disease”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
In the citing paper
“Rates of conversion to dementia, institutionalization, and mortality are significantly increased in these patients, identifying patients with VCI as an important target population for prevention. 3,8-11”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
In the citing paper
“However, these aspects have not been operationalized in current diagnostic criteria. 3”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
In the citing paper
“However, available diagnostic criteria vary with regard to sensitivity and specificity and are, thus, not interchangeable. 3,18,22-25”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
In the citing paper
“The efficacy of blood pressure (BP) lowering to prevent cognitive impairment in the elderly beyond stroke prevention is still controversial. 3”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
In the citing paper
“A number of ‘vascular’ risk factors, variably referred to as ‘cardiovascular’ or ‘cerebrovascular’, have been identified as increasing the risk of cognitive disorders.”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [24]
In the citing paper
“Emerging markers include carotid intimal-medial thickness and arterial stiffness, which are associated with arterial ageing and may serve as risk markers of VCD.24”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [24]
In the citing paper
“Vascular dementia, a heterogeneous group of brain disorders in which cognitive impairment is attributable to cerebrovascular pathologies, is responsible for at least 20% of cases of dementia, being second only to Alzheimer’s disease (AD) (Gorelick et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
In the citing paper
“Recent clinical-pathological studies have highlighted the role of cerebrovascular disease, not only as a primary cause of cognitive impairment, but also as an adjuvant to the expression of dementia caused by other factors, including AD and other neurodegenerative pathologies (Gorelick et al., 2011; Schneider et al., 2007a; Toledo et al., 2013).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
In the citing paper
“As for the other pathologies underlying VCI, there is a general correlation between the total burden of vascular pathology and cognitive deficits (Gelber et al., 2012; Gorelick et al., 2011; Inzitari et al., 2009).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
In the citing paper
“Confluent white matter lesions, the imaging correlate of which is termed leukoaraiosis (fig. 3), and lacunes, small (<1.5 cm) white matter infarcts typically in the basal ganglia, are common occurrence in VCI and are strongly associated with cardiovascular risk factors, especially hypertension, diabetes, hyperlipidemia and smoking (Gorelick et al., 2011; Wardlaw et al., 2013b).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
In the citing paper
“Advanced age is a powerful risk factor for VCI, and the prevalence and incidence of cognitive impairment increases exponentially after age 65 (Gorelick et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
In the citing paper
“The development of treatments for VCI has been hampered by the lack of a suitable animal model recapitulating the multifaceted features of the disease (Gorelick et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
In the citing paper
“Vascular dementia has seen a broadening of the concept to vascular cognitive impairment and dementia 156 , and new diagnostic criteria157, 158 have been proposed.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [156]
In the citing paper
“A number of vascular risk factors that should raise the index of suspicion have been recognized, 34 but these factors should not be used as diagnostic criteria.”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [34]
In the citing paper
“Vascular disease also predisposes to cognitive impairment in older adults.182”
In the citing paper
“however, cerebral infarcts and neurovascular dysfunction are the most important cerebrovascular pathologies,182 both of which may benefit from regular physical activity.”
In the citing paper
“Substantial evidence exists supporting the link between cognition and cardiovascular risk factors.10”
In the citing paper
“In particular, high blood pressure has been linked with the pathophysiology of MCI other than with Alzheimer disease and vascular dementia.10,11”
In the citing paper
“However, evidence from randomized clinical trials that treatment of hypertension reduces dementia risk and that there is a class-specific effect of drugs targeting ANGII and its receptors is lacking (3).”
From Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension (2016) · cites this paper as [3]
Citations
Cites
Items 401–526 of 526
Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study
Matsui, Y., Tanizaki, Y., Arima, H., Yonemoto, K., Doi, Y., Ninomiya, T., Sasaki, K., Iida, M., Iwaki, T., Kanba, S., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.155481 · Cited by 125
Aortic Distensibility and Retinal Arteriolar Narrowing: The Multi-Ethnic Study of Atherosclerosis
Cheung, N., Sharrett, A. R., Klein, R., Criqui, M. H., Islam, F. M. A., Macura, K. J., Cotch, M. F., Klein, B. E. K., & Wong, T. Y. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091926 · Cited by 124
Harboe, E., Tjensvoll, A. B., Maroni, S., Gøransson, L. G., Greve, O. J., Beyer, M. K., Herigstad, A., Kvaløy, J. T., & Omdal, R. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098301 · Cited by 124
Cognitive impairment risk: White matter hyperintensity progression matters
Silbert, L. C., Howieson, D. B., Dodge, H., & Kaye, J. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ad53fd · Cited by 123
Ward, N. L., & Lamanna, J. C. (2004) · Neurological Research · doi:10.1179/016164104x3798 · Cited by 122
Regional pattern of white matter microstructural changes in normal aging, MCI, and AD
Lee, D. Y., Fletcher, E., Martinez, O., Ortega, M., Zozulya, N., Kim, J., Tran, J., Buonocore, M., Carmichael, O., & DeCarli, C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c33afb · Cited by 122
Self-citationNeuropsychology of Cardiovascular Disease
(2001) · Psychology Press eBooks · doi:10.4324/9781410600981 · Cited by 122
Szekely, C. A., Green, R. C., Breitner, J. C. S., Østbye, T., Beiser, A. S., Corrada, M. M., Dodge, H. H., Ganguli, M., Kawas, C. H., Kuller, L. H., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000313933.17796.f6 · Cited by 121
Deary, I. J., & Batty, G. D. (2007) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2005.039206 · Cited by 121
Rosei, E. A., Rizzoni, G., Castellano, M., et al. (1995) · PubMed · Cited by 117
Depression and Cognitive Impairment in Newly Diagnosed Systemic Lupus Erythematosus
PETRI, M., NAQIBUDDIN, M., CARSON, K. A., WALLACE, D. J., WEISMAN, M. H., HOLLIDAY, S. L., SAMPEDRO, M., PADILLA, P. A., & BREY, R. L. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091366 · Cited by 117
Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging
Yasar, S., Corrada, M., Brookmeyer, R., & Kawas, C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.009 · Cited by 116
Jefferson, A. L., Tate, D. F., Poppas, A., Brickman, A. M., Paul, R. H., Gunstad, J., & Cohen, R. A. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01226.x · Cited by 115
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
Kang, J. H., Cook, N., Manson, J., Buring, J. E., Albert, C. M., & Grodstein, F. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26404 · Cited by 114
Piracetam for dementia or cognitive impairment
Flicker, L. A., & Evans, J. G. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001011 · Cited by 113
Vascular and cognitive functions associated with cardiovascular disease in the elderly
Cohen, R. A., Poppas, A., Forman, D. E., Hoth, K. F., Haley, A. P., Gunstad, J., Jefferson, A. L., Tate, D. F., Paul, R. H., Sweet, L. H., et al. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802014594 · Cited by 112
Rivastigmine for vascular cognitive impairment
Birks, J., McGuinness, B., & Craig, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004744.pub3 · Cited by 110
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study
Lopez, O. L., Kuller, L. H., Becker, J. T., Jagust, W. J., DeKosky, S. T., Fitzpatrick, A., Breitner, J., Lyketsos, C., Kawas, C., & Carlson, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159860.19413.c4 · Cited by 109
Education and the cognitive decline associated with MRI-defined brain infarct
Elkins, J. S., Longstreth, W. T., Manolio, T. A., Newman, A. B., Bhadelia, R. A., & Johnston, S. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228246.89109.98 · Cited by 108
Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging
Modrick, M. L., Didion, S. P., Sigmund, C. D., & Faraci, F. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00300.2009 · Cited by 108
Mid‐life adiposity factors relate to blood–brain barrier integrity in late life
Gustafson, D. R., Karlsson, C., Skoog, I., Rosengren, L., Lissner, L., & Blennow, K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01869.x · Cited by 107
Qiu, C., Xu, W., & Fratiglioni, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091663 · Cited by 107
Rivastigmine in subcortical vascular dementia
Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., & Bava, A. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00280-0 · Cited by 107
Zarow, C., Sitzer, T. E., & Chui, H. C. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0057-3 · Cited by 104
Self-citationNilsson, S. E., Johansson, B., Takkinen, S., Zarit, S., McClearn, G., Melander, A., & Berg, S. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0618-y · Cited by 104
COL4A1 Is Associated With Arterial Stiffness by Genome-Wide Association Scan
Tarasov, K. V., Sanna, S., Scuteri, A., Strait, J. B., Orrù, M., Parsa, A., Lin, P.-I., Maschio, A., Lai, S., Piras, M. G., et al. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.823245 · Cited by 104
Self-citationSimpson, J. E., Ince, P. G., Haynes, L. J., Theaker, R., Gelsthorpe, C., Baxter, L., Forster, G., Lace, G., Shaw, P. J., Matthews, F. E., et al. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01030.x · Cited by 104
Lithell, H., Hansson, L., Skoog, I., Elmfeldt, D., Hofman, A., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000133730.47372.4c · Cited by 104
Low dose aspirin and cognitive function in the women's health study cognitive cohort
Kang, J. H., Cook, N., Manson, J., Buring, J. E., & Grodstein, F. (2007) · BMJ · doi:10.1136/bmj.39166.597836.be · Cited by 103
Feigin, V. L., Ratnasabapathy, Y., & Anderson, C. S. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.020 · Cited by 103
Reliability of NINDS‐AIREN clinical criteria for the diagnosis of vascular dementia
Lopez, O. L., Larumbe, M. R., Becker, J. T., Rezek, D., Rosen, J., Klunk, W., & DeKosky, S. T. (1994) · Neurology · doi:10.1212/wnl.44.7.1240 · Cited by 103
Stroke and Vascular Cognitive Impairment
Hachinski, V. (2007) · Stroke · doi:10.1161/01.str.0000260101.08944.e9 · Cited by 102
Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences
Poorthuis, R. B., Goriounova, N. A., Couey, J. J., & Mansvelder, H. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.031 · Cited by 102
Cerebral Vascular Dysfunction During Hypercholesterolemia
Kitayama, J., Faraci, F. M., Lentz, S. R., & Heistad, D. D. (2007) · Stroke · doi:10.1161/strokeaha.107.481879 · Cited by 102
Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling
Arai, K., & Lo, E. H. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22256 · Cited by 101
Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia
Tranmer, B. I., Keller, T. S., Kindt, G. W., & Archer, D. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0253 · Cited by 100
Is there cognitive decline 1 year after CABG?: Comparison with surgical and nonsurgical controls
McKhann, G. M., Grega, M. A., Borowicz, L. M., Bailey, M. M., Barry, S. J. E., Zeger, S. L., Baumgartner, W. A., & Selnes, O. A. (2005) · Neurology · doi:10.1212/01.wnl.0000175220.78475.99 · Cited by 99
Carotid Intima-Media Thickness and Cognitive Function in Elderly Women: A Population-Based Study
Komulainen, P., Kivipelto, M., Lakka, T. A., Hassinen, M., Helkala, E.-L., Patja, K., Nissinen, A., & Rauramaa, R. (2007) · Neuroepidemiology · doi:10.1159/000108112 · Cited by 98
How to assess vascular remodelling in small and medium-sized muscular arteries in humans
Schiffrin, E. L., & Hayoz, D. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715060-00002 · Cited by 97
Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL
Mayer, M., Straube, A., Bruening, R., Uttner, I., Pongratz, D., Gasser, T., Dichgans, M., & Müller-Höcker, J. (1999) · Journal of Neurology · doi:10.1007/s004150050398 · Cited by 97
Shifts in Thinking About Dementia
Hachinski, V. (2008) · JAMA · doi:10.1001/jama.2008.525 · Cited by 97
Birns, J., Morris, R., Donaldson, N., & Kalra, L. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000244934.81180.16 · Cited by 96
Price, J. F., Stewart, M. C., Deary, I. J., Murray, G. D., Sandercock, P., Butcher, I., Fowkes, F. G. R., & Trialists, O. B. O. T. A. (2008) · BMJ · doi:10.1136/bmj.a1198 · Cited by 96
MRI Markers of Small Vessel Disease in Lobar and Deep Hemispheric Intracerebral Hemorrhage
Smith, E. E., Nandigam, K. R. N., Chen, Y.-W., Jeng, J., Salat, D., Halpin, A., Frosch, M., Wendell, L., Fazen, L., Rosand, J., et al. (2010) · Stroke · doi:10.1161/strokeaha.110.579078 · Cited by 95
Self-citationHatazawa, J., Shimosegawa, E., Satoh, T., Toyoshima, H., & Okudera, T. (1997) · Stroke · doi:10.1161/01.str.28.10.1944 · Cited by 94
COGNITIVE IMPAIRMENT AND AUTOANTLBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS
HANLY, J. G., WALSH, N. M., FISK, J. D., EASTWOOD, B., HONG, C., SHERWOOD, G., JONES, J. V., JONES, E., & ELKON, K. (1993) · Rheumatology · doi:10.1093/rheumatology/32.4.291 · Cited by 94
Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study
Cherubini, A., Martin, A., Andres-Lacueva, C., Di Iorio, A., Lamponi, M., Mecocci, P., Bartali, B., Corsi, A., Senin, U., & Ferrucci, L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.002 · Cited by 94
Selvetella, G., Notte, A., Maffei, A., Calistri, V., Scamardella, V., Frati, G., Trimarco, B., Colonnese, C., & Lembo, G. (2003) · Stroke · doi:10.1161/01.str.0000078310.98444.1d · Cited by 94
Neuropathology of mild cognitive impairment
Saito, Y., & Murayama, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00806.x · Cited by 92
Prevention of CIND by physical activity: Different impact on VCI-ND compared with MCI
Middleton, L. E., Kirkland, S., & Rockwood, K. J. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.04.054 · Cited by 91
Evans, J. G., & Sastre, A. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003804 · Cited by 91
Ankle-to-Brachial Index and Dementia: The Honolulu-Asia Aging Study
Laurin, D., Masaki, K. H., White, L. R., & Launer, L. J. (2007) · Circulation · doi:10.1161/circulationaha.106.686477 · Cited by 90
Self-citationRosano, C., Naydeck, B., Kuller, L. H., Longstreth, W. T., & Newman, A. B. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53208.x · Cited by 90
The determinants and longitudinal course of post-stroke mild cognitive impairment
SACHDEV, P. S., CHEN, X., BRODATY, H., THOMPSON, C., ALTENDORF, A., & WEN, W. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990579 · Cited by 90
Genome-Wide Association Studies of MRI-Defined Brain Infarcts
Debette, S., Bis, J. C., Fornage, M., Schmidt, H., Ikram, M. A., Sigurdsson, S. O., HEISS, G. M., Struchalin, M. V., Smith, A. V., van der Lugt, A., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.569194 · Cited by 90
Self-citationClinical and radiological determinants of prestroke cognitive decline in a stroke cohort
Pohjasvaara, T., Mantyla, R., Aronen, H. J., Leskela, M., Salonen, O., Kaste, M., & Erkinjuntti, T. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.742 · Cited by 86
Narasimhalu, K., Effendy, S., Sim, C. H., Lee, J. M., Chen, I., Hia, S. B., Xue, H. L., Corrales, M. P., Chang, H. M., Wong, M. C., et al. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01263.x · Cited by 85
Acupuncture improved cognitive impairment caused by multi-infarct dementia in rats
YU, J., LIU, C., ZHANG, X., & HAN, J. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.07.015 · Cited by 85
Behl, P., Bocti, C., Swartz, R. H., Gao, F., Sahlas, D. J., Lanctot, K. L., Streiner, D. L., & Black, S. E. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.266 · Cited by 84
Self-citationTreatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors
Erkinjuntti, T., Román, G., & Gauthier, S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.018 · Cited by 82
Self-citationLeisure Activities and Risk of Vascular Cognitive Impairment in Older Adults
Verghese, J., Wang, C., Katz, M. J., Sanders, A. E., & Lipton, R. B. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709332938 · Cited by 81
Dore, G. A., Elias, M. F., Robbins, M. A., Elias, P. K., & Nagy, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1497-2 · Cited by 81
Scuteri, A., Coluccia, R., Castello, L., Nevola, E., Brancati, A. M., & Volpe, M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp133 · Cited by 81
Self-citationAtrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men
Elias, M. F., Sullivan, L. M., Elias, P. K., Vasan, R. S., D’Agostino, R. B., Seshadri, S., Au, R., Wolf, P. A., & Benjamin, E. J. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.05.009 · Cited by 80
Self-citationViswanathan, A., Patel, P. V., Rahman, R. M. A., Nandigam, R. N. K., Kinnecom, C., Bracoud, L., Rosand, J. M., Chabriat, H., Greenberg, S. M., & Smith, E. E. (2008) · Stroke · doi:10.1161/strokeaha.107.509091 · Cited by 80
Self-citationSimpson, J. E., Hosny, O., Wharton, S. B., Heath, P. R., Holden, H. M., Fernando, M. S., Matthews, F. E., Forster, G., O'Brien, J. T., Barber, R., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.529214 · Cited by 80
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease
Silvestrini, M., Gobbi, B., Pasqualetti, P., Bartolini, M., Baruffaldi, R., Lanciotti, C., Cerqua, R., Altamura, C., Provinciali, L., & Vernieri, F. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.008 · Cited by 78
Mediterranean Diet and Mild Cognitive Impairment
Blass, J. P. (2009) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(09)79131-8 · Cited by 72
Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing
Dolan, D., Troncoso, J., Resnick, S. M., Crain, B. J., Zonderman, A. B., & O'Brien, R. J. (2010) · Brain · doi:10.1093/brain/awq141 · Cited by 70
Principles and Practice of Geriatric Psychiatry
Katz, I. R. (2012) · JAMA · doi:10.1001/jama.2012.206 · Cited by 69
Acupuncture for vascular dementia
Peng, W., Wang, Y., Zhang, Y., & Liang, C. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004987.pub2 · Cited by 67
van de Rest, O., Spiro, A., Krall-Kaye, E., Geleijnse, J. M., de Groot, L. C. P. G. M., & Tucker, K. L. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.113647 · Cited by 65
Liu-Ambrose, T., Eng, J. J., Boyd, L. A., Jacova, C., Davis, J. C., Bryan, S., Lee, P., Brasher, P., & Hsiung, G.-Y. R. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-14 · Cited by 64
Gorelick, P. B. (2005) · Stroke · doi:10.1161/01.str.0000158916.59742.7c · Cited by 62
Self-citationImaging of Static Brain Lesions in Vascular Dementia: Implications for Clinical Trials
Erkinjuntti, T., Bowler, J. V., DeCarli, C. S., Fazekas, F., Inzitari, D., O??Brien, J. T., Pantoni, L., Rockwood, K., Scheltens, P., Wahlund, L.-O., et al. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00013 · Cited by 62
Self-citationFioravanti, M., & Yanagi, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000269.pub2 · Cited by 61
Sabbagh, M. N., Shah, F., Reid, R. T., Sue, L., Connor, D. J., Peterson, L. K. N., & Beach, T. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1771 · Cited by 57
DIAGNOSTIC VALUE OF ULTRASTRUCTURAL SKIN BIOPSY STUDIES IN CADASIL
Malandrini, A., Gaudiano, C., Gambelli, S., Berti, G., Serni, G., Bianchi, S., Federico, A., & Dotti, M. T. (2007) · Neurology · doi:10.1212/01.wnl.0000264018.46335.c8 · Cited by 57
McGuinness, B., Todd, S., Passmore, A. P., & Bullock, R. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.118505 · Cited by 57
Rosei, E. A., Rizzoni, D., Castellano, M., et al. (1995) · Journal of Hypertension · doi:10.1097/00004872-199503000-00010 · Cited by 57
Hachinski, V. (2008) · Stroke · doi:10.1161/strokeaha.108.531681 · Cited by 55
Vascular factors and depression
Teper, E., & O'Brien, J. T. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2020 · Cited by 55
Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People?
Stott, D. J., Falconer, A., Kerr, G. D., Murray, H. M., Trompet, S., Westendorp, R. G. J., Buckley, B., De Craen, A. J. M., Sattar, N., & Ford, I. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02007.x · Cited by 55
Donepezil for vascular cognitive impairment
Malouf, R. S., & Birks, J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004395 · Cited by 54
Jagust, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07230-0 · Cited by 52
Plasma carotenoids and tocopherols and cognitive function: A prospective study
Kang, J. H., & Grodstein, F. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.006 · Cited by 52
Plasma β-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype
Gomis, M., Sobrino, T., Ois, A., Millán, M., Rodríguez-Campello, A., de la Ossa, N. P., Rodríguez-González, R., Jiménez-Conde, J., Cuadrado-Godia, E., Roquer, J., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.559641 · Cited by 52
A new de novo Notch3 mutation causing CADASIL
Coto, E., Menéndez, M., Navarro, R., García‐Castro, M., & Alvarez, V. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01337.x · Cited by 51
Huperzine A for vascular dementia
Hao, Z., Liu, M., Liu, Z., & Lu, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007365.pub2 · Cited by 48
Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease
Kalaria, R. N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.020 · Cited by 48
Buckman, J. F., Bates, M. E., & Morgenstern, J. (2008) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2008.69.738 · Cited by 48
Waldstein, S. R., Wendell, C. R., Seliger, S. L., Ferrucci, L., Metter, E. J., & Zonderman, A. B. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02618.x · Cited by 44
Vascular cognitive impairment: Today and tomorrow
Chui, H. C. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2006.03.003 · Cited by 44
Self-citationRivastigmine for vascular cognitive impairment
Craig, D., & Birks, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004744.pub2 · Cited by 42
Natté, R., Vinters, H. V., Maat-Schieman, M. L. C., Bornebroek, M., Haan, J., Roos, R. A. C., & van Duinen, S. G. (1998) · Stroke · doi:10.1161/01.str.29.8.1588 · Cited by 41
GAINOTTI, G., FERRACCIOLI, M., VITA, M. G., & MARRA, C. (2008) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617708080831 · Cited by 39
Rosengart, T. K., Sweet, J. J., Finnin, E., Wolfe, P., Cashy, J., Hahn, E., Marymont, J., & Sanborn, T. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.03.026 · Cited by 36
Arsenault, L. N., Matthan, N., Scott, T. M., Dallal, G., Lichtenstein, A. H., Folstein, M. F., Rosenberg, I., & Tucker, K. L. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp089 · Cited by 36
Nutrition in early life: a global priority
Victora, C. G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61725-6 · Cited by 35
Association between cognitive impairment and atrial fibrillation: A systematic review
Mead, G. E., & Keir, S. (2001) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2001.24663 · Cited by 35
Reversal of age-associated memory impairment by rosuvastatin in rats
Rech, R. L., de Lima, M. N. M., Dornelles, A., Garcia, V. A., Alcalde, L. A., Vedana, G., & Schröder, N. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.02.001 · Cited by 35
Depressive Symptoms, Major Depressive Episode and Cognition in the Elderly: The Three-City Study
Godin, O., Dufouil, C., Ritchie, K., Dartigues, J.-F., Tzourio, C., Pérès, K., Artero, S., & Alpérovitch, A. (2007) · Neuroepidemiology · doi:10.1159/000101508 · Cited by 33
Self-citationRetinopathy as an indicator of silent brain infarction in asymptomatic hypertensive subjects
Kwon, H.-M., Kim, B. J., Oh, J. Y., Kim, S. J., Lee, S.-H., Oh, B.-H., & Yoon, B.-W. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.11.003 · Cited by 33
Thalamic disequilibrium syndrome after thrombolytic therapy for acute myocardial infarction
Nandhagopal, R., Vengamma, B., Krishnamoorthy, S. G., Rajasekhar, D., & Subramanyam, G. (2005) · Neurology · doi:10.1212/01.wnl.0000171339.96234.b5 · Cited by 32
Lack of Association Between Apolipoprotein E Polymorphism and Vascular Dementia in Koreans
Kim, K. W., Youn, J., Han, M., Paik, N., Lee, T. J., Park, J. H., Lee, S. B., Choo, I. H., Lee, D. Y., Jhoo, J. H., et al. (2008) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988707311028 · Cited by 31
Cosentino, F., Battista, R., Scuteri, A., De Sensi, F., De Siati, L., Di Russo, C., Camici, G. G., & Volpe, M. (2009) · Stroke · doi:10.1161/strokeaha.108.520627 · Cited by 30
Self-citationVascular characteristics of patients with dementia
Morović, S., Jurašić, M.-J., Martinić Popović, I., Šerić, V., Lisak, M., & Demarin, V. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.330 · Cited by 29
Management of dementia with a cerebrovascular component
Bocti, C., Black, S. E., & Frank, C. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.07.009 · Cited by 29
Self-citationMagnetic Resonance Imaging Traits in Siblings Discordant for Alzheimer Disease
Cuenco, K. T., Green, R. C., Zhang, J., Lunetta, K., Erlich, P. M., Cupples, L. A., Farrer, L. A., DeCarli, C., & for the MIRAGE Study Group (2008) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00191.x · Cited by 27
Self-citationTreatment of Vascular Dementia and Vascular Cognitive Impairment
Demaerschalk, B. M., & Wingerchuk, D. M. (2007) · The Neurologist · doi:10.1097/01.nrl.0000252919.46622.28 · Cited by 27
Sertraline Improves Executive Function in Patients With Vascular Cognitive Impairment
Royall, D. R., Cordes, J. A., Román, G., Velez, A., Edwards, A., Schillerstrom, J. S., & Polk, M. J. (2009) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2009.21.4.445 · Cited by 26
Self-citationAkiguchi, I., Tomimoto, H., Wakita, H., Kawamoto, Y., Matsuo, A., Ohnishi, K., Watanabe, T., & Budka, H. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0850-2 · Cited by 25
Yamada, M., Mimori, Y., Kasagi, F., Miyachi, T., Ohshita, T., & Sasaki, H. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.338 · Cited by 24
Cardiovascular Risk Factors and Cognitive Functioning: An Epidemiological Perspective
(2001) · Psychology Press eBooks · doi:10.4324/9781410600981-13 · Cited by 18
Neuropathology-Based Risk Scoring for Dementia Diagnosis in the Elderly
Haneuse, S., Larson, E., Walker, R., Montine, T., & Sonnen, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1105 · Cited by 15
Atherosclerosis and Cognitive Functioning
Everson‐Rose, S. A., Helkala, E., Kaplan, G. A., & Salonen, J. T. (2001) · Psychology Press eBooks · doi:10.4324/9781410600981-14 · Cited by 13
Huperzine A for vascular dementia
Hao, Z., Liu, M., Liu, Z., & Lv, D. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007365 · Cited by 12
Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10
Physical Activity and Cognitive Function in Alzheimer Disease
Wu, S. (2009) · JAMA · doi:10.1001/jama.2008.1011 · Cited by 10
Low Blood Pressure and Risk of Dementia in the Kungsholmen Project
Qiu, C., Strauss, E. I. V., Fastbom, J., Winblad, B. G., & Fratiglioni, L. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.223 · Cited by 9
Depressive Symptoms and Cognitive Decline in Nondemented Elderly Women: A Prospective Study
Yaffe, K., Blackwell, T., Gore, R., Sands, L., Reus, V., & Browner, W. S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.425 · Cited by 8
Vascular cognitive impairment: prodrome to VaD?
Mayda, A., & DeCarli, C. (2009) · Vascular Cognitive Impairment in Clinical Practice · doi:10.1017/cbo9780511575976.003 · Cited by 7
Self-citationCognitive Changes 5 Years After Coronary Artery Bypass Grafting: Is There Evidence of Late Decline?
Selnes, O. A., Royall, R. M., Grega, M. A., Borowicz, Jr., Quaskey, S., & McKhann, G. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.4.598 · Cited by 4
Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study
Khachaturian, A. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.noc60013 · Cited by 3
Predictors of Preclinical Alzheimer Disease and Dementia: A Clinicopathologic Study
Galvin, J. E., Powlishta, K. K., Wilkins, K., McKeel, D. W., Xiong, C., Grant, E., Storandt, M., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.758 · Cited by 2
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Flagged first, then by citations
12 of the 538 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: World Health Organization; 1993.
- Report of the Stroke Progress Review Group. Bethesda, MD: National Institute of Neurological Disorders and Stroke; 2002.
- Safar M, O'Rourke MF eds. Arterial Stiffness in Hypertension: Handbook of Hypertension, Volume 23. New York, NY: Elsevier; 2006.
- Roose S, Sneed JR. The current status of vascular depression. US Psychiatry. 2007; 1: 21–23.
Cited by
Sorted by citations
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Self-citationMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Self-citationThe Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Self-citationMechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Metadata
- Authors
- Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., Petersen, R. C., Schneider, J. A., Tzourio, C., Arnett, D. K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R., Nilsson, P. M., Roman, G. C., Sellke, F. W., & Seshadri, S.
- Affiliations
- Alzheimer's Association (US)
- ORCID
- Gorelick, Philip B.
- Scuteri, Angelo
- Black, Sandra E.
- DeCarli, Charles
- Greenberg, Steven M.
- Iadecola, Costantino
- Launer, Lenore J.
- Nyenhuis, David
- Petersen, Ronald C.
- Schneider, Julie A.
- Tzourio, Christophe
- Arnett, Donna K.
- Bennett, David A.
- Chui, Helena C.
- Higashida, Randall T.
- Nilsson, Peter M.
- Sellke, Frank W.
- Seshadri, Sudha
- Venue
- Stroke
- Published
- 2011-09
- Volume
- 42
- Issue
- 9
- Pages
- 2672-2713
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- PMC
- PMC3778669
- OpenAlex
- W2527609605
- Semantic Scholar
- 349ef695d4a2dbdc85f5b635237c9068ec61b2ba
- Cited by
- 3,811
- References
- 538
- Citations by year
- 2026: 244 · 2025: 292 · 2024: 295 · 2023: 237 · 2022: 263 · 2021: 269 · 2020: 314 · 2019: 320 · 2018: 270 · 2017: 253 · 2016: 258 · 2015: 227 · 2014: 238 · 2013: 169 · 2012: 137
- FWCI
- 23.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- American Heart Association
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Massachusetts General Hospital
- University of Southern California
- University of Minnesota
- University of Pittsburgh
- Minneapolis Heart Institute
- Rush University
- Daiichi-Sankyo
- University of Toronto
- Eisai
- Servier
- H. Lundbeck A/S
- National Institutes of Health
- University of Illinois at Urbana-Champaign
- Weill Cornell Medical College
- University of California, Davis
- National Institute on Aging (P30AG010129, R01AG021028, R01AG020098, U19AG010483)
- National Institute of Neurological Disorders and Stroke (R01NS017950)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- vascular cognitive impairment, dementia, mild cognitive impairment, neurovascular unit, cerebral autoregulation, cerebral amyloid angiopathy, Alzheimer's disease, white matter hyperintensities, stroke risk factors, atrial fibrillation, hypertension, diabetes mellitus, hypercholesterolemia, neuroimaging, prevention, treatment
- MeSH terms
- Alzheimer Disease, American Heart Association, Mental Disorders, Cerebral Angiography, Humans, Male, Risk Factors, United States, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review